WELCOME TO THE AANEM ANNUAL MEETING...Silent Auction | Lone Star Ballroom Foyer Visit the Silent...

1

1

1

WELCOME TO THE AANEM ANNUAL MEETING

ANTHONY E. CHIODO, MD, MBA, AANEM & ANF PRESIDENT

Greetings from Austin, Texas! It’s great to see so many new and familiar faces attending the premier event for health care professionals in NM and EDX medicine. Our goal for the 2019 AANEM Annual Meeting is to provide everyone with further expertise and help you better serve your patients. I hope you’re ready for an illuminating week full of sessions, workshops, and opportunities designed to expand your medical knowledge, provide insight into the latest developments in our field, and make lasting professional connections that will continue to foster camaraderie in NM and EDX medicine.

Our plenary sessions involve experts who are at the forefront of how technology will impact future treatments for patients with NM diseases. Technological advances are rapidly occurring in the areas of robotics, computerization, mobility aids, and others. Each of our speakers will share how they believe technology will translate to improved patient care and the continued cultivation of future technological breakthroughs.

Another exciting aspect of the AANEM Annual Meeting is showcasing all of the outstanding research submitted by our colleagues. I hope all of you will spare a few moments this week to visit the Poster Hall, view the abstracts, and interact with poster presenters about their research findings. Enjoy the enthusiasm these presenters have for their research and congratulate the various AANEM award recipients for Best Abstract, President’s Research Initiative Awards, Residency and Fellowship Member Awards, and Medical Student Awards.

I imagine that most of you are here for the unmatched educational experiences you’ll be receiving, along with the networking and leadership opportunities. I have developed relationships with physicians around the country through these meetings, many of which I now call great friends. We all bring something different to the organization, and I personally learn and gain so much from our interactions together. There will be several opportunities to engage in the planned social activities during the week, where you’ll get your chance to network and find some like-minded colleagues in your field.

If you haven’t yet joined AANEM, I encourage you to join this wonderful community of neurologists, physiatrists, technologists, researchers, and collaborators who are all dedicated to improving the lives of patients with NM diseases. Our talented AANEM Staff will be on hand all week to answer any questions you may have about the benefits of membership.

Have a great time here in Texas!

2

Table of ContentsNeed to Know InfoAnnual Meeting HoursSocial Event HoursCME InformationCEUs & CNCT Checkpoint InformationEnjoy Your StayLevel 2 MapLevel 3 MapLevel 4 MapAnnual Meeting Collection & Workshop E-BundlePlenary SpeakersSchedule DescriptionsWednesday ScheduleThursday ScheduleFriday ScheduleSaturday Schedule2019 AANEM Achievement Awards2019 Abstract Award WinnersPoster Hall DiagramAANEM ChallengeExhibitorsExhibit Hall DiagramAANEM Corporate SupportersAANEM Foundation ContributorsAANEM Advocacy ContributorsAcknowledgments & Appreciation2018-2019 Board of DirectorsAbbreviationsSpeaker IndexMeeting Objectives & Policies

3456789101112

1314152535465053566162707476777879808187

3

Need to Know InfoDownload Our Meeting AppGet the latest information by using the AANEM 2019 Annual Meeting App, sponsored by CSL Behring. Meeting changes, as well as important messages, will be found in the app. You can also manage your schedule, find your way around,

take notes, share fun photos, participate in the AANEM Challenge, and so much more!

Find it in your device’s app store by searching “AANEM 2019” and be sure you uninstall any old AANEM apps from

your device before downloading the 2019 app. Use your user name and password from your AANEM account to log into the 2019 app after you install it.

Get Free WiFiWiFi is FREE throughout the 2019 AANEM Annual Meeting event space compliments of Grifols USA, LLC. Select the AANEM network and use the password Grifols2019.

Please note: Your WiFi connection in the JW Marriott will be different outside of AANEM meeting spaces.

Claim Meeting CME, CEUs, and CNCT Education CreditsEverything you need to know about claiming your CME, CEUs, and CNCT Checkpoints for the meeting can be found on pages 6 and 7.

View our Workshop BoardAll workshops with open slots will be displayed on the Workshop Board near the Registration Booth. If you find a workshop you’d like to attend, please stop by the Registration Booth to sign up. Residents/Fellows – Use Rush Tickets and SaveWorkshops with openings are offered to residents and fellows at NO CHARGE. Residents and fellows can determine which workshops are available at the Registration Booth. Rush tickets will be handed out 15 minutes before the start of each workshop.

Share Your Experience on Social MediaUse social media? Have you liked and followed AANEM yet? Visit our pages and be sure to share your meeting updates and photos on your own social media pages throughout the week.

Facebook.com/AANEMorg Twitter.com/AANEMorgUse this hashtag - #AANEMinAUSTIN

4

Registration Booth | JW Grand Ballroom FoyerVisit the Registration Booth to register for the meeting and add workshops to your registration.

AANEM Booth | JW Grand Ballroom FoyerStop by the AANEM Booth and the staff there will be happy to assist you with any questions related to membership, ABEM certification, lab accreditation, coding, and more!

Speaker Ready Room | Room 305Faculty and Speakers: before delivering your presentations, please visit the Speaker Ready Room to make changes to your presentation and/or get it loaded appropriately. AV staff will be on hand to transfer your presentation to the appropriate session room. Please load your presentation at least 1 hour prior to your session start time to allow enough time for AV staff to transfer it to the proper location.

Exhibit Hall | JW Grand BallroomThe Exhibit Hall is a great place to meet and network with industry professionals including representatives from equipment, technology, and pharmaceutical companies.

Product Store | JW Grand Ballroom FoyerThe AANEM Product Store offers products that meet ABPN and ABPMR MOC requirements for both performance improvement and self-assessment CME. We will have some products available for purchase, samples of other products, and we will assist you with online ordering. More information is available atwww.aanem.org/Education/All-Education-Products.

Silent Auction | Lone Star Ballroom FoyerVisit the Silent Auction to benefit the American Neuromuscular Foundation. All money raised will be used by the foundation to fund scientific research on NM diseases.

Poster Hall | Griffin HallTake time to stroll through the Poster Hall to view the research submitted for the annual meeting. Poster authors will be available on Thursday and Friday, during the Abstract Poster Sessions.

Annual Meeting Hours

TuesdayRegistration Booth: 6:00 pm – 9:00 pmAANEM Booth: 6:00 pm - 9:00 pmSpeaker Ready Room: 7:30 pm – 9:00 pm

WednesdayRegistration Booth: 6:30 am – 6:00 pm AANEM Booth: 8:00 am - 5:00 pmSpeaker Ready Room: 7:00 am – 4:00 pmExhibit Hall: 5:45 pm – 7:15 pm Product Store: 8:00 am – 5:00 pmSilent Auction: 8:00 am – 8:00 pm

ThursdayRegistration Booth: 7:00 am – 6:00 pm AANEM Booth: 8:00 am – 5:00 pmSpeaker Ready Room: 7:00 am – 4:00 pmExhibit Hall: 9:00 am – 4:00 pmProduct Store: 8:00 am – 5:00 pm Silent Auction: 8:00 am – 4:00 pm Poster Hall: 7:30 am – 9:00 pm

FridayRegistration Booth: 7:00 am – 4:00 pm AANEM Booth: 8:00 am – 4:00 pm Speaker Ready Room: 7:00 am – 4:00 pm Exhibit Hall: 9:00 am – 4:00 pmProduct Store: 8:00 am – 4:00 pm Silent Auction Pickup: 10:00 am – 4:00 pm Poster Hall: 7:30 am – 4:00 pm

SaturdayRegistration Booth: 7:00 am – 10:00 amSpeaker Ready Room: 7:00 am – 11:30 am

5

Social Event HoursCoffee Breaks | Various locations. See schedule.Enjoy free coffee and use break time to network and socialize with your colleagues.

Speed Networking | Lone Star Ballroom FoyerBuild connections with peers, leaders, and other professionals in NM and EDX medicine by attending our speed networking event (space is limited). Don’t forget your business cards!

President’s Reception | JW Grand BallroomThis is the official kickoff event of the meeting each year. Socialize with attendees and exhibitors while enjoying complimentary appetizers, wine, and refreshments.

Abstract Poster Sessions | Griffin HallStop by the Poster Hall during our Poster Sessions on Thursday and Friday to meet abstract authors and discuss their research.

Abstract Award Reception | Lone Star Ballroom FoyerEnjoy an evening celebrating research! Socialize with colleagues and abstract authors while enjoying complimentary food, wine, beer and other refreshments. Winning and runner-up authors for Best Abstract and President’s Research awards will be available for discussion of their research.

EMG Talk| Lone Star G-HEMG Talk is an interactive, entertaining event meant to be a lighthearted look at EMG with lots of laughs. Join the fun and camaraderie! Drinks and sweet treats will be available. Sponsored by Natus Neuro.

AANEM Lounge | Lone Star Ballroom FoyerLooking for a fun, laid-back place to relax and hang out with your colleagues? Visit the AANEM Lounge. This social area was created to be a fun, comfortable, congregational space for meeting attendees. Inside you’ll find a charging station and a media wall featuring social media postings and meeting photos. Caricature artists and musicians will provide entertainment during some coffee breaks and the reception. Media wall sponsored by Grifols USA, LLC.

WednesdayCoffee Break: 9:30 am – 10:00 am Lone Star Ballroom FoyerLounge Event: 9:30 am – 10:15 amLounge Event: 11:30 am – 12:30 pmSpeed Networking: 3:00 pm – 3:45 pmCoffee Break: 3:00 pm – 4:00 pm Lone Star Ballroom FoyerLounge Event: 3:00 pm – 4:00 pmPresident’s Reception: 5:45 pm – 7:15 pm

ThursdayCoffee Break: 9:30 am – 10:00 am JW Grand BallroomAbstract Poster Session I: 1:00 pm – 1:30 pm | Posters: 1-127Coffee Break: 3:00 pm – 4:00 pm JW Grand BallroomAbstract Poster Session II: 3:30 pm – 4:00 pm | Posters: 1-127 Abstract Award Reception: 5:45 pm – 6:45 pmLounge Event: 5:45 pm – 6:45 pmEMG Talk: 7:00 pm – 9:00 pm

FridayCoffee Break: 9:30 am – 10:00 am JW Grand BallroomAbstract Poster Session III: 1:00 pm – 1:30 pm | Posters: 128-248Coffee Break: 3:00 pm – 4:00 pm JW Grand Ballroom FoyerAbstract Poster Session IV: 3:30 pm – 4:00 pm | Posters: 128-248 Lounge Event: 5:30 pm – 6:30 pmHappy Hour: 5:30 pm - 6:30 pm Lone Star South Foyer

SaturdayCoffee Break: 9:30 am – 10:00 am Lone Star Ballroom Foyer

6

CME InformationPhysician CME CreditsPhysicians can earn up to 22 AMA PRA Category 1 CreditsTM by attending sessions at this meeting. CME credits are listed in this program. Record your CME credits via www.aanem.org/cmeform. Be sure to record your CME before December 15.

Self-Assessment CME For PhysiciansPhysicians can also earn up to 27 Self-Assessment (SA) CME at this meeting.

The following sessions are designated for Part II SA credit toward maintenance of certification for physicians. Of the 10 available sessions, you must attend 2 for every 9 SA CMEs you would like to earn. Due to ABPN & ABPMR guidelines, SA CME will only be given for every combination of 2 sessions you attend. AANEM will report completion of SA activities to the ABPN and ABPMR on December 20. Note: some sessions are scheduled at the same time, so the max available SA CMEs is 27.

Wednesday, October 16Hot Topics in NM Literature – Part 1 | 8:00 am-9:30 amHot Topics in NM Literature – Part 2 | 10:00 am-11:30 am

Thursday, October 17Combined Use of EDX and US for Evaluation of the Brachial Plexus and Upper Limb Nerves – Part 1 | 1:30 pm-3:00 pmCombined Use of EDX and US for Evaluation of the Brachial Plexus and Upper Limb Nerves – Part 2 | 4:00 pm-5:30 pmUpdates of Demyelinating Neuropathies/Jointly provided by the AANEM and the PNS | 1:30 pm-3:00 pmDiagnosis and Treatment Breakthroughs in Genetic Testing | 4:00 pm-5:30 pmMUAP Recruitment Analysis Made Simple | 4:00 pm-5:30 pm

Friday, October 18NMJ Disorders Part 1 | 1:30 pm-3:00 pmNMJ Disorders Part 2 | 4:00 pm-5:30 pmALS | 1:30 pm-3:00 pm

These sessions are free to attend for CME credit. AANEM members also have free access to claim SA CME credit. Nonmembers pay $50 for every 9 SA CME.

Physician Credit RecordingFor all hours of participation in general sessions, record your CME credits via the recording form (www. aanem.org/cmeform). Attendees are responsible for recording all CME credit from sessions on your own using the CME recording form.

The CME recording form must be submitted by December 15, 2019. Credit submitted after this date will incur a $25 late fee and will not be reported to ABPN or ABPMR.

Credit for workshops will be automatically recorded for you by AANEM.

In order to receive SA CME credit, physicians must complete a post-test with a 70% passing rate. AANEM will record 9 SA CME for every 2 successful post-tests. The post-test will be available on our website after the session ends: www.aanem.org/mtg-sa

7

CEUs & CNCT Checkpoint Information CEU Credits For Technologists/NonphysiciansMeeting attendees may earn up to 22 CEU credits by attending sessions at this meeting. CEU Credits are listed in this program. Record your CEU hours via www.aanem.org/ceuform. Be sure to record your CEU before December 15.

CNCT CheckpointsTechnologists can receive a total of 5 Checkpoint credits at this meeting. One Checkpoint credit is given to members and nonmembers for attending the meeting! No action is required for this credit, aside from attending the entire meeting. Technologists can attend the following sessions to earn up to 4 additional Checkpoints toward CNCT maintenance of certification through the American Board of Electrodiagnostic Medicine (ABEM). Checkpoint credit is available upon completion of a post-test and AANEM will report completion to ABEM for you.

Friday, October 18Peripheral Anatomy: From Root to Muscle | 1:30 pm-3:00 pmUpper Extremity NCS: Lesion Localization and Severity Assessment | 4:00 pm-5:30 pm

Saturday, October 19Demyelinating Neuropathies | 8:00 am-9:30 amNeurodiagnostic Jeopardy: Let Us Get on Your Nerves! |10:00 am-11:30 am

These sessions are free to attend for CEU credit. AANEM members also have free access to claim Checkpoint credit. Nonmembers pay $50 for every Checkpoint credit.

CEU/Checkpoint RecordingFor all hours of participation in general sessions, record your CEU credits via the recording form (www. aanem.org/ceuform). Attendees are responsible for recording all CEU credit from sessions on your own using the CEU recording form.

The CEU recording form may be submitted until December 15, 2019. Credit submitted after this date will incur a $25 late fee.

Credit for workshops will be automatically recorded for you by AANEM.

In order to receive Checkpoint credit, technologists must complete a post-test with a 70% passing rate. AANEM will record 1 Checkpoint credit for every successful post-test. The post-test will be available on our website after the session ends: www.aanem.org/mtg-checkpoints

2019 AANEM Annual Meeting: Industry Forum

BACK IN TOUCH WITH PATIENT NEEDS: Treatment advances in hATTR amyloidosis with polyneuropathyThursday, October 17th | 7:00 – 8:00 AM (Registration begins at 6:45 AM)JW Marriott Grand Ballroom 3-4

This program is not part of the official scientific program of the AANEM. This event is neither sponsored by nor endorsed by the AANEM. This event does not qualify for continuing education credit.

©2019 Akcea Therapeutics, Inc. All rights reserved. US-TEG-1900093 02/19

Come visit Akcea Therapeutics at Booth #101

Breakfast provided

by AANEM

8

What are the highlights of the JW Marriott Austin?You will find top-notch amenities at this resort:• Beautiful Edge Pool + Cabanas• Several bars and restaurants • Starbucks on site• The posh Spa by JW• Brand new Edge Rooftop + Bar with beautiful

birds-eye views• The Burger Bar, JW’s food truck without wheels

concept• Some of the largest guestrooms in downtown

Austin• Wireless Internet access throughout the hotel

(higher speeds in room available for purchase)• Daily newspaper delivery upon request

What bars and restaurants are available in this resort?• OP Italian (lunch and dinner)• Corner Restaurant (lunch and dinner)• Burger Bar (breakfast, lunch, and dinner)• Edge Rooftop + Bar (lunch and dinner)• JW Marriott Austin Lobby Bar (lunch and

dinner)• Starbucks

Is smoking allowed at the hotel?• No. This hotel is smoke-free.

Outside of the AANEM Annual Meeting, what else is there to do in the Austin, Texas area?• Numerous nearby biking and jogging trails• Downtown Business District• Bob Bullock State Museum• The Lyndon B. Johnson Library & Museum• Historic Sixth Street• Paramount Theatre• 2nd Street District• South Congress Ave Shopping District• Texas Music Museum• Austin was recently ranked No. 1 on the

Golf.com list of “The 10 Best Golf Cities in America.”

• Live music everywhere! There are more than 250 live music venues in the city.

Visit Austintexas.org for more attractions.

Enjoy Your Stay

Image courtesy of Bullock Texas State History Museum.

9

Level 2

Poster Hall

Sessions

Workshop subject waiting area

10

Level 3

Sessions

Coffee Breaks (Wednesday & Saturday)

AANEM Lounge

Silent Auction

Plenary and Sessions

11

Industry Forums

Exhibit Hall (Thursday & Friday Coffee Breaks)

Presentation Stage

Level 4

Membership/Products

ABEM/Lab Accreditation Booth

Registration Booth

Career Center/Muscle & Nerve

12

Buy Now

$300(through October 19)

Price after the meeting:$450 (members)

$780 (nonmembers)

Bring the Meeting Home!

Buy Now

$75(through October 19)

Price after the meeting:$100 (members)

$250 (nonmembers)

2019 Annual Meeting CollectionWith so many great sessions offered at the 2019 AANEM Annual Meeting, it would be impossible to attend every session in person. However, AANEM has a solution - the 2019 Annual Meeting Collection, a digital download of session presentations. The download includes the presentation slides and the presenter’s audio commentary for most sessions at the meeting*.

Purchasers of the 2019 Annual Meeting Collection can receive CME/CEUs for sessions in which CME/CEUs were offered at the meeting. The link to the digital download will be available approximately 2 weeks after the annual meeting.

*The 2019 Annual Meeting Collection contains most of the session presentations; however, it does not include Ask the Experts sessions, sessions that experience technical difficulty during recording, and workshop materials. Workshop materials are available in the Workshop E-bundle. See the next page for more information on workshop materials.

2019 Workshop E-BundleAANEM is offering a variety of workshops at the 2019 Annual Meeting, including some that have never been offered before! Due to the nature of the workshop setting (e.g. hands-on demonstrations), AANEM encouragesin-person attendance. However, if in-person attendance is not possible for all of the workshops you are interested in, AANEM offers the 2019 Annual Meeting Workshop E-Bundle.

Purchasers of this bundle will receive handouts from all workshops that utilize handouts (35 or more) via a single, downloadable PDF. These handouts contain the teaching points of the workshops; however, the workshops are not recorded and audio/video is not available.

Workshop CME/CEUs are only available for in-person attendance. Workshop CME/CEUs cannot be obtained by purchasing the 2019 Workshop E-Bundle.

13

Paul S. Cederna, MD, FACS

Use of Regenerative Peripheral Nerve

Interfaces for Control of Neuroprosthetic

DevicesReiner Lecture

Arun Jayaraman, PT, PhD

Future of Rehabilitation Robotics Research and

Practice

Lisa D. Hobson-Webb, MD

Emerging Technologies in NM US

Lambert Lecture

FRIDAY | 10:00 AM - 12:00 PM

SATURDAY | 10:00 AM - 12:00 PM

Plenary Speakers

Zachary Simmons, MD

The Use of Telemedicine to Enhance Care in ALS

and Other NMDs Olney Lecture

Madeline Corrigan, PhD

Key Considerations for Upper Extremity

Exoskeleton Technology Development for

Individuals With DMD and the Importance of User-Centered Design

WEDNESDAY | 4:00 PM - 5:45 PM

THURSDAY | 10:00 AM - 12:00 PM

The following speakers will share their expertise as it relates to the present and future role of technology in the lives of patients with NM diseases. Their work is at the forefront of a rising tide of science producing groundbreaking cures and treatments that, in the long term, could transform the way we help those afflicted with these diseases.

Dennis J. McFarland, PhD

Brain-Computer Interface Applications for Individuals With

NMDs

THURSDAY | 10:00 AM - 12:00 PM FRIDAY | 10:00 AM - 12:00 PM

14

Sessions are included with your AANEM Annual Meeting registration.

Your registration gives you access to a wide variety of educational sessions related to NM, MSK, and EDX medicine. We have a diverse group of meeting attendees each year whose learning needs are different. To cover the spectrum, we have sessions on the basics for those in the early stages of their career (or those who just need a refresher) as well as advanced sessions for seasoned professionals. There is something for everyone! Each attendee can tailor their learning by choosing the offerings most applicable to their practice. Most sessions offer CME and CEUs.SE

SSIO

NS

WO

RKSH

OPS

SOC

IAL

EVEN

TSCustomize Your Experience

Social events are included with your AANEM Annual Meeting registration.

All registered attendees are invited to the meeting’s social events which include Speed Networking, President’s Reception, Exhibit Hall, Abstract Poster Sessions, Abstract Award Winners’ Reception, Coffee Breaks, and EMG Talk. These events do not offer CME/CEUs. Registered guests are welcome at all social events (except Speed Networking).

Enhance your learning experience by adding workshops to your registration.

To customize your meeting experience, you may choose to add workshops to your registration. Workshops focus on teaching a technique or a concept. Most workshops involve learning in small groups, led by experts in the field. Some workshops offer room for larger groups and provide information through demonstrations by experts in the field. Almost all of our workshops offer CME and some offer CEUs.

NOTE: Most workshops are held throughout the day on Wednesday and Saturday. They have limited seating and require advance registration. Workshop locations are found on registered attendees’ tickets. All workshops are open to physicians. Technologists may attend workshops where CEUs are being offered. Workshops with openings will be noted on the Workshop Board near the Registration Booth. Residents and fellows, ask about free workshop tickets at the Registration Booth (see page 3 for details).

IND

UST

RYFO

RUM

S Industry Forums are included with your AANEM Annual Meeting registration.

Each Industry Forum is comprised of a 60-minute presentation on a topic related to a disease state, research findings, products, or services. Registered meeting attendees may attend Industry Forums free of charge and breakfast, lunch, and/or light appetizers will be provided by AANEM. Industry Forums have limited seating, so if you’d like to attend one or all of them, be sure to arrive early to secure a spot. Please note that Industry Forums are sponsored and not part of the official scientific program of AANEM. CME is not provided by AANEM.

15 Wednesday | October 16

Interested in learning more about accrediting your lab?Curious about ABEM, NM Ultrasound or CNCT certification?

Visit the Accreditation and ABEM booth in the JW Grand Ballroom Foyer on the 4th floor.

Stop by during breaks to learn more about the accreditation process or eligibility requirements for ABEM or CNCT

certification.

Neuromuscular Ultrasound CAQ and MOCP Exam information is also available for current diplomates.

6:45 am - 8:00 am

IndustryForum

Industry ForumJW Grand Ballroom 3-4

The Natural History of Spinal Muscular Atrophy in Adult Patients

Sponsored by: Biogen

This session will review the natural history of later-onset SMA and a treatment clinical profile, indicated for pediatric and adult patients.

Presenters:Sally Evans, MD (HCP presenter)Diana A (Ambassador presenter)

This activity is sponsored by Biogen and is not part of the official scientific program of AANEM.

Food will be provided by AANEM for session attendees. Seating is limited.

6:45 am: Registration7:00 am: Presentation

No CME/CEU

8:00 am - 9:30 am

Session

Hot Topics in NM Literature - Part 1Lone Star D

Appraise several impactful findings in NM literature over the past year; recognize the clinical value of these studies and their impact to NM patients (EDX and sonographic methods, hereditary and acquired myopathy evaluation, peripheral neuropathy testing and treatment, motor neuron disease understanding and NMJ disorder advancements); describe hot topics and groundbreaking work in these areas of NM medicine; and integrate emerging knowledge into clinical practice.

This is a Self-Assessment (SA) CME session. To receive the SA CME credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.

8:00 am: Introduction Ruple S. Laughlin, MD

8:05 am: Hot Topics in Clinical Neurophysiology Ruple S. Laughlin, MD

8:30 am: Emerging Therapies in Neuromuscular Junction Disorders Vern C. Juel, MD

1.5 CME/CEU9:00 am: Breakthroughs in Motor Neuron Disease Shafeeq S. Ladha, MD

8:00 am - 9:30 am

Session

EDX NM Challenging Cases - Part 1Lone Star E

Apply and refine the process of diagnostic formulation in NM medicine and clinical EMG and improve patient care. This session relies on attendees to provide challenging cases.

1.5 CME/CEU8:00 am: EDX NM Challenging Cases - Part 1 Bashar Katirji, MD

16Wednesday | October 16

8:00 am - 9:30 am

Session

Cutting Edge USLone Star C

Illustrate the role of NM US in an EDX laboratory with particular attention to how it changes the diagnostic process and patient care; demonstrate the role of muscle US in diagnosing DMD and monitoring its progression; and critically evaluate the latest developments in NM US and how they relate to current clinical and research practices.

8:00 am: Introduction Lisa D. Hobson-Webb, MD

8:05 am: Changing the World of Electrodiagnostic Medicine Through Ultrasound David C. Preston, MD

8:30 am: Neuromuscular Imaging in Duchenne Muscular Dystrophy Craig Zaidman, MD

1.5 CME/CEU

8:55 am: Latest Developments in Neuromuscular Ultrasound: Publications from the last 12 Months Sarada Sakamuri, MD

8:00 am - 9:30 am

Workshop

W02A Autonomic Testing Using Live Demonstration

Perform the two quantitative tests for autonomic function, quantitative sudomotor axon reflex testing and heart rate variability studies; and apply this technique to standard EDX practice where appropriate.

1.5 CME Jasvinder P. Chawla, MBBS, MD, MBA

8:00 am - 9:30 am

Workshop

W11A EMG and US Respiratory

Perform phrenic NCSs; utilize techniques for safe needle EMG of the diaphragm (including US assisted); localize and perform needle EMG of chest wall muscles, which are helpful in the diagnosis of respiratory failure; and utilize US for evaluating thickness and contractility of the diaphragm.

1.5 CME William J. Litchy, MD

8:00 am - 9:30 am

Workshop

W18A NM US

Obtain images with transverse and longitudinal transducer positions; describe how to manipulate basic US instrumentation to include focal depth, Doppler flow, and transducer frequency; describe how muscle, nerve, and tendon appear with US; and discuss the principle of anisotropy.

1.5 CME/CEU Michael S. Cartwright, MD

8:00 am - 9:30 am

Workshop

W21A NCS Pitfalls

Identify common instrumentation, physiologic, and operator errors; alter recording electrode montages and use the instrument’s filters to help optimize the recording of motor and sensory potentials; and minimize stimulus artifact interference with waveform recording.

1.5 CME/CEU Bassam A. Bassam, MD

8:00 am - 9:30 am

Workshop

W22A Skin Biopsy Technique & Applications

Discuss the development of skin biopsy as a clinical technique; describe its current applications and limitations in clinical practice; and discuss the technique involved in obtaining skin specimens to increase providers’ comfort level in performing this billable procedure in their own office.

1.5 CME David W. Polston, MD

8:00 am - 9:30 am

Workshop

W31A SFEMG Basic/Advanced

Acquire skills in SFEMG recordings using volitional and axonal microstimulation techniques, using a SFEMG needle.

1.5 CME James M. Gilchrist, MD

8:00 am - 9:30 am

Workshop

W67A US-Guided Treatment of Peripheral Mononeuropathies

Describe the technical aspects of US-guided needle placement; utilize US-guided procedures to treat common peripheral neuropathies; and demonstrate the ability to track a needle under real-time US guidance in order to quickly and accurately target a structure through a hands-on approach.

1.5 CME/CEU John W. Norbury, MD


8:00 am - 9:30 am

Workshop

W70A Expert US

Demonstrate advanced US practices involving challenging and complicated nerves and measurement techniques of the peripheral nerve in the upper and lower limbs.

1.5 CME/CEU Jeffrey A. Strakowski, MD

8:00 am - 9:30 am

Workshop

W72A Blink Reflex

Discuss the principles and practice of eliciting the blink reflex with electric stimulation or by mechanical taps; and identify the clinical values and limitations of the blink reflex as an EDX study.

1.5 CME/CEU Jun Kimura, MD

8:00 am - 8:00 pm

Social Event

Silent AuctionLone Star Ballroom Foyer

All money raised from the Silent Auction goes to the American Neuromuscular Foundation to provide funds for scientific research on NM diseases.

8:00 am - 12:45 pm

Session

MGFA SessionLone Star F-G-H

The Myasthenia Gravis Foundation of America (MGFA) Medical/Scientific Advisory Board presents a scientific session highlighting research in the area of MG and myasthenic disorders. This session is the premier annual event around the U.S. and world related to the pathogenesis, immunology, diagnosis, and treatment of MG and related disorders of the NMJ. Included in the program will be leaders in MG research from the scientific and clinical areas.

8:00 am: Welcome Nancy Law

8:00 am: Welcome Edward Walsh, CPA

8:15 am: Keynote: What Do We Expect and What Can We Learn from Registries, Observational Studies, Small Experiments and Clinical Trials Gary Cutter, PhD, [email protected]

8:45 am: The Adverse Event Unit (AEU): A Novel Metric to Measure the Burden of Treatment Adverse Events Michael K. Hehir, MD

9:00 am: Survivin is a Negative Regulator of Apoptosis in MG: A Human and Animal Model Study Linda L. Kusner, MD

9:15 am: Origins and Characteristics of Autoantibody-Producing B Cells in MG Miriam Fichtner, MD

9:30 am: In-Depth Immune Profiling of Treatment-Naive MG Patients Jeffrey T. Guptill, MD

9:45 am: Break (during the break, poster authors will stand by their posters for questions)

10:45 am: Multi-Center Study of LRP4 and Agrin Antibodies in MG Michael H. Rivner, MD

10:50 am: Sensitivity of Neurophysiologic Tests Regarding the NMJ in Patients With Congenital Myasthenic Syndromes Vitor Marques Caldas, MD

10:55 am: Phenotypic Variation Between Early Onset and Late Onset MG Pragma L. Roy, MD, FRCPC

11:00 am: MG Patient and Physician Opinions About Immunosuppressant Dose Reduction Michael K. Hehir, MD

11:05 am: Minimal Manifestation Status and Prednisone Withdrawl in the MGTX Trial Ikjae Lee, MD

11:10 am: A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Amifampridine Phosphate in Patients with Musk Antibody Positive MG Stanley Iyadurai, MD, PhD, MSc

11:15 am: Rituximab in Patients With Moderate to Severe MG: A Subgroup Analysis of the BEATMG Study Richard J. Nowak, MD, MS

11:30 am: Promise-MG: A Prospective Multi-Center Observational Study of the Comparative Effectiveness of Treatments for MG: Preliminary Results Pushpa Narayanaswami, MBBS, DM

11:45 am: Break

11:55 am: Zilucoplan, A Self-Administered Subcutaneous Peptide Inhibitor of Complement Component 5 (C5) for the Treatment of Generalized MG: Phase 2 Results James F. Howard, MD

12:10 pm: Efgartigimod in MG: Update on Clinical Development and Phase 3 Adapt Study Jon Beauchamp

No CME/CEU

12:25 pm: Long-Term Efficacy of Eculizumab in Refractory Generalized MG: Responder Analyses James F. Howard, MD


9:30 am - 10:15 am

Social Event

Caricature Artist in the AANEM LoungeLone Star Ballroom Foyer

Visit the AANEM Lounge to get a cartoon likeness created of yourself or just watch caricatures emerge of other meeting attendees.

9:30 am - 10:00 am

Social Event

Coffee BreakLone Star Ballroom Foyer

Enjoy free coffee and use break time to network and socialize with your colleagues.

10:00 am - 11:30 am

Session

Hot Topics in NM Literature - Part 2Lone Star D

Appraise several impactful findings in NM literature over the past year; recognize the clinical value of these studies and their impact to NM patients (EDX and sonographic methods, hereditary and acquired myopathy evaluation, peripheral neuropathy testing and treatment, motor neuron disease understanding and NMJ disorder advancements); describe hot topics and groundbreaking work in these areas of NM medicine; and integrate emerging knowledge into clinical practice.


10:00 am: Cutting Edge Myopathy-Inherited and Acquired Mohamed Kazamel, MD

10:40 am: Recent Highlights in Peripheral Nerve Literature Michelle L. Mauermann, MD

1.5 CME/CEU 11:20 am: Discussion and Q & A

10:00 am - 11:30 am

Session

EDX NM Challenging Cases - Part 2Lone Star E

Apply and refine the process of diagnostic formulation in NM medicine and clinical EMG and improve patient care. This session relies on attendees to provide challenging cases.

1.5 CME/CEU10:00 am: EDX NM Challenging Cases Bashar Katirji, MD

10:00 am - 11:30 am

Session

Effective Strategy in a Multidiscipline ClinicLone Star C

Identify individuals who need multidisciplinary care and how to provide information to them; identify and select appropriate health care personnel; determine the clinic’s physical location; consider clinical care, research, and data; develop skills related to billing, copays and production of pamphlets, publications and courses; determine how to assess progress and be able to describe what not to do.

10:00 am: Goals and Pitfalls in Establishing a Multidisciplinary Clinic: What to Do, What Not to Do, My Mistakes, Identification, Location, Control of Personnel David B. Rosenfield, MD

10:25 am: Clinical Care, Research and Collection Data Ericka P. Simpson, MD

10:50 am: Key Attributes to Consider When Building a Multidisciplinary Center Stephanie Staten


10:00 am - 11:30 am

Session

Respiratory Management of the NM Patient - Part 1Lone Star B

In the adult NM patient, evaluate the respiratory status, including airway clearance; identify and manage sleep related breathing disorders; and utilize devices to evaluate pulmonary function and manage airway clearance and ventilation.

10:00 am: Introduction Ericka P. Simpson, MD

10:05 am: The Evaluation and Management of Respiration in Your Neuromuscular Patient: Why, How and What Sheetal Shroff, MD

10:30 am: Pulmonary 101 for the Adult Neuromuscular Specialist Eric M. Davis, MD

10:55 am: Sleep related Breathing Dysfunction in the Neuromuscular Patient Aparajitha K. Verma, MD



10:30 am - 12:00 pm

Workshop

W05B Cranial NCS and EMG Testing

Perform neurophysiological testing of the cranial nerves including blink reflexes and jaw jerk; seventh NCSs; and eleventh nerve testing; and discuss EMG of key muscles that complement the cranial NCS.

1.5 CME Jun Kimura, MD

10:30 am - 12:00 pm

Workshop

W08B EMG Laryngeal

Develop skills in the clinical and EDX evaluation of vocal cord dysfunction, including perform specific EDX testing of the larynx and discuss how to evaluate which tests to perform on patients presenting with hoarseness and laryngeal dysfunction.

1.5 CME Michael C. Munin, MD

10:30 am - 12:00 pm

Workshop

W27B Repetitive Nerve Stimulation

Perform RNS to shoulder, upper arm, hand, and facial muscles; and discuss sequential examination for detecting NM transmission defects, such as artifacts.

1.5 CME/CEU Taylor B. Harrison, MD

10:30 am - 12:00 pm

Workshop

W35B Needle EMG of the Foot

Discuss the anatomy of the tibial nerve branches in the foot (including the medial plantar nerve, lateral plantar nerve, and Baxter's nerve) and the deep peroneal nerve branches in the foot; identify the potential entrapment sites for these nerve branches; distinguish the anatomic basis for needle placement; discuss special considerations for the technique in each muscle; and identify how to develop a meaningful interpretation of findings.

1.5 CME Tracy A. Park, MD

10:30 am - 12:00 pm

Workshop

W44B Anatomy & Kinesiology of the Shoulder/Upper Limb

Identify the normal anatomy and the normal and abnormal kinesiology resulting from paralysis of key upper limb muscles; perform the neurological examination on each other to localize root from peripheral nerve lesions; differentiate winging from serratus anterior versus trapezius muscle weakness; and localize lesions to specific peripheral nerve sites based on the motor and key components of the sensory and reflex examination and integrate with EDX and US findings. Participants are requested to wear short sleeve shirts to facilitate examining each other.

1.5 CME John W. Norbury, MD

10:30 am - 12:00 pm

Workshop

W50B Advanced Autonomic Testing

Familiarize participants with 3 quantitative tests of autonomic function using specialized equipment designed for autonomic reflex function testing including sudomotor testing; cardiovagal testing with heart-rate response to deep breathing; and Valsalva maneuver testing to evaluate cardiovagal and adrenergic function.

1.5 CME Amanda C. Peltier, MD, MS

10:30 am - 12:00 pm

Workshop

W59B US Guidance for Neurotoxins

Discuss the pros and cons of using in-plane and out-of-plane US views to guide needle placement; compare and contrast the use of EMG needle guidance, nerve stimulation, and US for identifying neurotoxin targets in patients; and identify common targets for needle-guided injections using US.

1.5 CME Katharine E. Alter, MD

10:30 am - 12:00 pm

Workshop

W60B MSK US of Upper Limb

Explain which transducer frequencies are optimal for imaging upper extremity joints in adults; provide a differential diagnosis of joint pain in the upper extremity; identify key landmarks in upper extremity joints using US; and describe the pathologic changes of tendon rupture, tear, and inflammation.

1.5 CME/CEU Lester S. Duplechan, MD


10:30 am - 12:00 pm

Workshop

W76B Basic US of Upper Limb Nerves

Describe basic principles of US imaging and equipment requirement; demonstrate scanning technique of the median and ulnar nerves, dynamic testing and measurements; and discuss sonographic findings of common entrapment neuropathies. This workshop will focus on the median and ulnar nerves from the elbow to wrist.

1.5 CME/CEU Elena Shanina, MD, PhD

10:30 am - 12:00 pm

Workshop

W78B Chemodenervation for Head and Neck Conditions: Dystonia, Sialorrhea, Migraine

Recognize the various conditions of the head and neck that can be treated with botulinum neurotoxins (BoNT); identify the commonly involved muscles in cervical dystonia; localize the BoNT injection sites for the various conditions involving the face (dystonias, sialorrhea, migraine headaches); and discuss how to use needle EMG and US to help guide BoNT injections for head and neck conditions.

1.5 CME Atul T. Patel, MD

10:30 am - 12:00 pm

Workshop

W84B Advanced US of Brachial Plexus

Explain recommended transducer frequencies and image optimization methods for imaging of brachial plexus; explain sono-anatomy of the brachial plexus and adjacent structures; demonstrate scanning technique of the brachial plexus in the interscalene groove as well as supraclavicular, infraclavicular and axillary areas; demonstrate sonographic identification of the following nerves: vagus, phrenic, dorsal scapular, long thoracic, suprascapular and spinal accessory; and summarize expected findings of brachial plexopathies as may be seen on US and findings in structures other than the nerve that may be significant.

1.5 CME/CEU Monika Krzesniak-Swinarska, MD

11:30 am - 12:30 pm

Social Event

Caricature Artist in the AANEM LoungeLone Star Ballroom Foyer

Visit the AANEM Lounge to get a cartoon likeness created of yourself or just watch caricatures emerge of other meeting attendees.

12:00 pm - 1:15 pm

IndustryForum


Respiratory Involvement in Neuromuscular Disorders: Pompe Disease as a Prototype

Sponsored by: Sanofi Genzyme

Late-Onset Pompe Disease (LOPD) is a rare, metabolic disease primarily affecting the musculoskeletal and respiratory systems. As LOPD tends to affect the whole body, there are several outcome measures that are used to assess disease progression within a patient. Domains that have been frequently assessed include respiratory capacity, exercise capacity and endurance, symptoms, and global assessments. Forced vital capacity (FVC) is a measure of respiratory function that is among the more commonly reported outcomes assessed in LOPD patients. FVC is an objective and reproducible parameter that is readily measurable across most settings; however, associations between FVC and other LOPD outcomes remain unclear. This symposium will focus on the spectrum of symptoms in Pompe disease with particular attention to respiratory function.

Presenters:Kenneth Berger, MDNYU, Division of Pulmonary, Critical Care, and Sleep Medicine

Mazen M. Dimachkie, MDDept. of Neurology, Kansas University Medical Center

This activity is sponsored by Sanofi Genzyme and is not part of the official scientific program of AANEM.


12:00 pm: Registration12:15 pm: Presentation

No CME/CEU


1:30 pm - 3:00 pm

Session

History of EDX and NM DiseasesLone Star G-H

Identify historical/landmark discoveries related to current electrophysiologic techniques; relate current NM disease conditions to their original descriptions; and articulate the historical evolution of our understanding of the etiology and pathology of certain NM disorders.

1:30 pm: Introduction Mohamed Kazamel, MD

1:35 pm: Charcot Marie Tooth Disease: Historical Perspectives and Evolution Mohamed Kazamel, MD

2:00 pm: The Historical Perspectives of the Electrodiagnostic Differentiation of Demyelinating Versus Axonal Neuropathies John C. Kincaid, MD

2:25 pm: The Early History of Myasthenia Gravis J. David Avila, MD

1.5 CME/CEU 2:50 pm: Discussion and Q & A

1:30 pm - 3:00 pm

Session

Women in NM MedicineLone Star A

Articulate the challenges and opportunities facing women in medicine and identify resources and methods of addressing gender bias in the workplace.

1:30 pm: Introduction Dianna Quan, MD

1:40 pm: Negotiation Summary Sandra L. Hearn, MD

2:05 pm: Updated Survey Results and Background Holli A. Horak, MD

1.5 CME/CEU2:05 pm: Updated Survey Results and Background Kamakshi Patel, MD, MPH

1:30 pm - 3:00 pm

Session

Respiratory Management of the NM Patient - Part 2Lone Star B

Demonstrations and hands-on learning stations.

1:30 pm: Demonstration and Hands-On Learning Session Eric M. Davis, MD

1.5 CME/CEU1:30 pm: Demonstration and Hands-on Learning Session Aparajitha K. Verma, MD

1:30 pm - 3:00 pm

Workshop

W10C EMG Needle Basics

Utilize electrophysiologic techniques related to needle EMG; apply a problem-directed approach to the study; identify insertional and spontaneous activity; and identify the characterization of MUAP morphology and recruitment in normal and diseased states.

1.5 CME Atul T. Patel, MD

1:30 pm - 3:00 pm

Workshop

W20C Office-Based Injection Procedures

Describe the principles underlying the safe and effective performance of office-based procedures; identify contraindications to select office-based injection procedures, identify appropriate patients, prepare and instruct them on what to expect during and after a procedure; describe and demonstrate commonly performed office-based injection procedures, including trigger-point injections, shoulder and knee injections, bursal injections, carpal tunnel injections, and botulinum toxin injections for migraine and cervical dystonia; become aware of the complications that may result from office-based injection procedures, how to minimize the chance of complications, and manage complications if they arise; and describe how the use of US to guide needle placement can enhance accuracy and understand when it is most appropriately used as well as its limitations.

1.5 CME Michael D. Stubblefield, MD

1:30 pm - 3:00 pm

Workshop

W45C Cervical Radiculopathy/Brachial Plexopathy

Discuss the anatomy of the cervical roots and the brachial plexus; describe the role of the sensory NCS in the initial localization of axon loss processes to preganglionic versus ganglionic/postganglionic; illustrate the role of the sensory NCS in localizing focal lesions to specific regions of the brachial plexus (root, trunk, division, cord, terminal nerve); discuss the role of motor NCS in further localizing the lesion and in defining its severity; describe the role of the needle EMG in confirming the NCS findings and in defining the temporal features of the disorder (slowly progressive, rapidly progressive, acute, subacute, chronic); and demonstrate this information using illustrative cases.

1.5 CME Mark A. Ferrante, MD


1:30 pm - 3:00 pm

Workshop

W55C Myopathies: EDX Approach

Discuss the role of EDX testing in myopathies; identify EDX findings in muscle disorders; determine muscle selection criteria for EDX in patients with suspected myopathy; and use the EDX findings to generate a differential diagnosis.

1.5 CME Hani A. Kushlaf, MD

1:30 pm - 3:00 pm

Workshop

W57C MSK US of Lower Limb

Explain which transducer frequencies are typically used for imaging lower extremity joints in adults; override a differential diagnosis of lower extremity joint pain; identify key landmarks in lower extremity joints using US; and describe the pathologic changes of tendon rupture, tear, and inflammation.

1.5 CME/CEU Jeffrey A. Strakowski, MD

1:30 pm - 3:00 pm

Workshop

W66C Telehealth for ALS

This workshop will provide an introduction into the ways clinical video telehealth (CVT) can be used to improve patient access to specialty ALS care. Hardware, software, and documentation options will be presented. Several models of telehealth delivered to clinical and home settings will be demonstrated. Participants will have the opportunity to perform hands-on telehealth from scheduling to evaluation of persons with ALS.

Ileana Howard, MD

1.5 CME/CEU Michael A. Elliott, MD

1:30 pm - 3:00 pm

Workshop

W73C Sonographic Needle Guidance for Carpal Tunnel Injections

Explain sono-anatomy of the carpal tunnel and adjacent structures; discuss approaches for sonographic needle imaging; compare US-guided and “blind method” injections for treatment of CTS; and distinguish structural abnormalities and common anatomic variations that may affect the procedure.

1.5 CME Elena Shanina, MD, PhD

1:30 pm - 3:00 pm

Workshop

W75C Chemodenervation Guidance Techniques-EMG, Nerve Stimulation and US

Discuss how to use US, needle EMG and nerve stimulation to guide chemodenervation injections using botulinum toxin; describe the benefits and limitations of each localization technique for chemodenervation procedures; and discuss ways to combine US with EMG/nerve stimulation to maximize ability to target and select muscles for chemodenervation.

1.5 CME Michael C. Munin, MD

1:30 pm - 3:00 pm

Workshop

W76C Basic US of Upper Limb Nerves

Describe basic principles of US imaging and equipment requirement; demonstrate scanning technique of the median and ulnar nerves, dynamic testing and measurements; and discuss sonographic findings of common entrapment neuropathies. This workshop will focus on the median and ulnar nerves from the elbow to wrist.

1.5 CME/CEU Sarada Sakamuri, MD

1:30 pm - 3:00 pm

Workshop

W81C Basic US of Lower Limb Nerves

Explain optimal transducer frequencies for imaging lower extremity nerves and appropriate choice of transducers; describe echogenicity and methods of demonstrating Morton’s neuroma in the foot; identify and trace the sciatic nerve from the ischiofemoral outlet into the posterior thigh; identify common muscles for EMG and chemodenervation and methods of safe approaches with needle; describe and demonstrate the branching patterns of sciatic, tibial, fibular and sural nerves in the lower extremities; list expected findings of nerve entrapment as may be seen on US and findings in structures other than nerve that may be significant. This workshop will focus on the sciatic nerve at bifurcation, fibular nerve at fibular head and the tibial at ankle.

1.5 CME/CEU Lester S. Duplechan, MD


WiFi is FREE throughout the 2019 AANEM Annual Meeting event space compliments of Grifols USA, LLC. Select the AANEM

network and use the password Grifols2019.

Get Free WiFi

1:30 pm - 3:00 pm

Workshop

W82C NCS Basics

Participants will acquire skills to place the stimulating and recording electrodes for optimal recordings; adjust the stimulation intensity and duration; adjust machine settings for appropriate recordings; and discuss common technical issues regarding basic NCSs.

1.5 CME/CEU Ghazala R. Hayat, MD

1:30 pm - 3:00 pm

Workshop

W85C Advanced US of Lower Limb Nerves

Explain recommended transducer frequencies and image optimization methods for imaging of lower extremity nerves; demonstrate scanning technique and measurement of the following nerves: femoral, saphenous, obturator and LFCN; describe and demonstrate the branching pattern of fibular nerve; discuss sonographic findings of the most frequent abnormalities affecting these nerves; and list expected findings in structures other than nerve that may be significant. This workshop will focus on the femoral, saphenous, obturator, LFCN and fibular.

1.5 CME/CEU Steven J. Shook, MD

1:30 pm - 3:00 pm

Session

Dysautonomia InternationalLone Star C

Recognize the presentation of postural orthostatic tachycardia syndrome in a clinical setting; accurately diagnose postural orthostatic tachycardia syndrome and common co-morbidities; utilize standard treatments for the condition; and know when to refer patients to speciality centers for more advanced treatments when necessary.

1:30 pm: Demographics & Physiology of Postural Orthostatic Tachycardia Syndrome Steven Vernino, MD, PhD

1:55 pm: Autonomic Testing for Postural Orthostatic Tachycardia Syndrome Kamal R. Chémali, MD

2:20 pm: Treatment of Postural Orthostatic Tachycardia Syndrome Brent P. Goodman, MD

No CME/CEU2:45 pm: Discussion and Q&A

3:00 pm - 3:45 pm

Social Event

Speed NetworkingLone Star Ballroom Foyer

Are you looking for a fun, easy way to network at the AANEM Annual Meeting? Do you want to build connections with peers, leaders, and other professionals in NM and EDX medicine? Register to attend our speed networking event (space is limited). Speed networkers will make approximately 10 connections during the session, so don’t forget your business cards!

3:00 pm - 4:00 pm

Social Event

Local Musical Artist in the AANEM LoungeLone Star Ballroom Foyer

Relax in the AANEM Lounge while listening to the music of a local artist.

3:00 pm - 4:00 pm

Social Event



24

4:00 pm - 5:45 pm

Session

Plenary 1: The Present & Future Role of Technology in the Lives of Patients With NM DiseasesLone Star D-E

Recognize how telemedicine can enhance the care of patients with ALS and other NMDs.

Note: AANEM's Annual Business Meeting will be held at the beginning of this session. Fellow, Active, and Research members will have the opportunity to vote and are encouraged to attend.

4:00 pm: Introduction A. Gordon Smith, MD

4:05 pm: Technology in the Care of Persons with Neuromuscular Disease Anthony E. Chiodo, MD, MBA

4:25 pm: Annual Business Meeting: Election of Officers Anthony E. Chiodo, MD, MBA

4:30 pm: Activities and Financial Overview Anthony E. Chiodo, MD, MBA

4:35 pm: Recognize Outgoing Members Anthony E. Chiodo, MD, MBA

4:40 pm: Introduction Anthony E. Chiodo, MD, MBA

4:45 pm: The Use of Telemedicine to Enhance Care in ALS and Other Neuromuscular Disorders Zachary Simmons, MD

5:25 pm: Awards: Best Abstract, Best Abstract Runner-up, Medical Student Research Awards, Residency and Fellowship Member Awards Anthony E. Chiodo, MD, MBA

1.0 CME/CEU5:40 pm: Closing Anthony E. Chiodo, MD, MBA

5:45 pm - 7:15 pm

Social Event

Exhibit HallJW Grand Ballroom

Want to learn more about the products that make our industry unique? Take the opportunity to stop by and see the latest innovations in our industry.

5:45 pm - 7:15 pm

Social Event

President's ReceptionJW Grand Ballroom

The President’s Reception is the official kickoff event of the meeting each year. Socialize with attendees and exhibitors while enjoying appetizers, wine, and refreshments.

Wednesday | October 16

Just search for theAANEM 2019 Annual

Meeting Appin your app store and download it to your

device! Sponsored by CSL Behring

Download our Annual Meeting

App Today!

25 Thursday | October 17

6:45 am - 8:00 am

IndustryForum

Industry Forum JW Grand Ballroom 3-4

BACK IN TOUCH WITH PATIENT NEEDS: Treatment advances in hATTR amyloidosis with polyneuropathy

Sponsored by: Akcea Therapeutics

In this innovative patient-moderated program, our expert speakers will discuss how early diagnosis and treatment is critical in managing hATTR amyloidosis with polyneuropathy, and the effects of a newly-approved therapy on progression of neuropathy and patient quality of life.

This activity is sponsored by Akcea Therapeutics and is not part of the official scientific program of AANEM.



No CME/CEU

7:30 am - 9:00 pm

Social Event

Poster HallGriffin Hall

Take time to stroll through the Poster Hall to view research submitted for the annual meeting. Poster authors will be available at specified times to discuss their research.

8:00 am - 9:30 am

Session

EDX Evaluation of CIDP and MMNBrazos

Articulate the algorithmic approach for the diagnosis of CIDP and MMN which includes defining the clinical phenotype in the context of the clinical history, identifying the EDX findings of acquired demyelination, and using validated EDX criteria (or supportive criteria) to determine the diagnosis.

This is an “Ask the Experts” session. There will be an interactive discussion designed around audience participation. There are no handouts nor a planned presentation and this session will not be included in the Annual Meeting Collection.

1.5 CME/CEU Said R. Beydoun, MD

8:00 am - 9:30 am

Session

Small Fiber NeuropathyRoom 302

For small fiber neuropathy, identify symptoms and signs; explain the utilities of individual diagnostic tests and order appropriate diagnostic tests; perform individualized thorough small fiber neuropathy etiology evaluation; identify treatment based on underlying causes and symptoms; and discuss the prognosis with patients.


1.5 CME/CEU Lan Zhou, MD, PhD

8:00 am - 9:30 am

Session

Diabetic NeuropathyRoom 301

Recognize the many faces of diabetic neuropathy (diabetic small fiber and autonomic neuropathies), the NM complications that arise, and employ treatment options.


1.5 CME/CEU Jau-Shin Lou, MD, PhD, MBA

8:00 am - 9:30 am

Session

ChemodenervationRoom 304

Articulate the principles and practical aspects of chemodenervation with botulinum toxins in focal dystonia and spasticity; recognize the role of EMG guidance in identification of dystonic EMG patterns and choice of candidate muscles for injection; and identify dosing differences/relationships among available toxins.


1.5 CME/CEU Janice M. Massey, MD

26Thursday | October 17

8:00 am - 9:30 am

Session

RadiculopathyRoom 307

With regard to lumbosacral and cervical radiculopathies, discuss pertinent historical features; integrate a pertinent physical and EDX examination that ensures high diagnostic accuracy; utilize other diagnostic tests and treatment options to improve your care of patients.


1.5 CME/CEU Peter A. Grant, MD

8:00 am - 9:30 am

Session

Botulinum Toxin for PainRoom 306

Discuss the various pain conditions that are treated with botulinum neurotoxin (BoNT); describe BoNT’s proposed mechanisms of action in painful conditions; identify various techniques used to treat pain conditions with BoNT; and summarize literature about BoNT that supports its treatment of painful conditions as well as its limitations.


1.5 CME/CEU Atul T. Patel, MD

8:00 am - 9:30 am

Session

How to Incorporate Genetic TestingRoom 309

Use an algorithmic approach to ordering genetic tests for patients with suspected hereditary NMDs.


1.5 CME/CEU Anthony A. Amato, MD

8:00 am - 9:30 am

Session

Writing a Journal Article: A Discussion With the Editor of Muscle & NerveRoom 308

Journals such as Muscle & Nerve receive far more submissions than they publish. While the quality of the science is always paramount, other factors such as organization, clarity, brevity, and grammar impact the recommendations of reviewers and decisions of editors. Attendees will be able to immediately implement writing improvements to the research they submit for publication to maximize the probability of acceptance.


1.5 CME/CEU Zachary Simmons, MD

8:00 am - 9:30 am

Session

Autonomic Disorders in Your PracticeLone Star B

For gastrointestinal and genitourinary autonomic dysfunction, orthostatic intolerance, and small fiber neuropathy describe the presentation; utilize an evaluation method; and apply the symptomatic treatment measures to your patients for each disorder.

8:00 am: Introduction Benn E. Smith, MD

8:05 am: Gastrointestinal and Genitourinary Autonomic Dysfunction Jasvinder P. Chawla, MBBS, MD, MBA

8:30 am: Orthostatic Intolerance Julie Khoury, MD

8:55 am: Current Concepts in Small Fiber Neuropathy Benn E. Smith, MD



8:00 am - 9:30 am

Session

EMG ReportsLone Star F

Convey important information about radiculopathies in EMG reports to referring physicians; identify information necessary for inclusion in an EMG report; and implement appropriate degree of clinical and EDX interpretation into a meaningful EMG report.

8:00 am: Do Referring Physicians Understand our EMG Reports? Elizabeth A. Mauricio, MD

8:20 am: EMG Report Formulation Kerry H. Levin, MD

8:40 am: Is a Clinical Interpretation (Beyond the EDX Interpretation) Helpful or Harmful to the Referring Physician? Devon I. Rubin, MD


8:00 am - 9:30 am

Session

NM Video CasesLone Star G-H

Articulate significant physical signs of different NM disorders; guide laboratory investigations based on accurate identification of leading findings; use EDX tests as an extension of the clinical examination; state how to longitudinally follow disease progress; and differentiate between functional and organic NM disorders.

1.5 CME/CEU Aziz Shaibani, MD

8:00 am - 9:30 am

Session

US Guided ProceduresLone Star A

Describe the role of US in enhancing the safety and accuracy of different procedures performed in the EMG lab and MSK outpatient practice setting including facilitating needle EMG of high risk structures, near nerve needle placement for unusual NCS, interventional techniques for the treatment of peripheral nerve pain, including ulnar neuropathy, CTS, meralgia parasthetica, occipital neuralgia, and suprascapular neuropathy, and US assisted carpal tunnel release techniques.

8:00 am: US to Enhance Needle EMG and NCS Andrea J. Boon, MD

8:20 am: US Guided Nerve Blocks Peter Inkpen, MD

1.5 CME/CEU9:00 am: US Guided Incisionless Carpal Tunnel Release Jeffrey S. Brault, DO

8:00 am - 9:30 am

Session

New NM Therapies: Integrative MedicineLone Star C

Integrate nutrition, supplements and mind body therapies into treatments for peripheral neuropathy and mitochondrial myopathies; recognize various acupuncture modalities such as manual acupuncture, electroacupuncture and moxibustion; examine acupuncture equipment and needles; observe and/or experience acupuncture and identify patients that may benefit from its various modalities.

8:00 am: Acupuncture for the Treatment of Perpheral Neuropathy - Conceptual Framework and Summary of the Evidence Alexandra K. Dimitrova, MD, MA

8:20 am: Integrative Approaches in Peripheral Neuropathy Jinny Tavee, MD

8:40 am: Integrative Approaches for Mitochondrial Myopathies Ilene S. Ruhoy, MD, PhD

9:00 am: Acupuncture Demonstration Alexandra K. Dimitrova, MD, MA

9:00 am: Acupuncture Demostration Ilene S. Ruhoy, MD, PhD


8:00 am - 9:30 am

Workshop

W23R Unusual NCS-Resident/Fellow

Limited to residents/fellows and medical students only. Participants will be able to identify less commonly used NCSs and discuss pitfalls associated with common NCSs.

Registration for this workshop includes a lunch on Friday, October 18 at 12 pm.Sponsored by Grifols USA, LLC

No CME/CEU Lawrence R. Robinson, MD

8:00 am - 4:00 pm

Social Event

Silent AuctionLone Star Ballroom Foyer

All money raised from the Silent Auction goes to the American Neuromuscular Foundation to provide funds for scientific research on NM diseases. Auction closes at 4:00 pm and winners will be notified.


9:00 am - 4:00 pm

Social Event

Exhibit hallJW Grand Ballroom


9:30 am - 10:00 am

Social Event

Coffee BreakJW Grand Ballroom


9:40 am - 10:00 am

Session

Presentation Stage by Corinthian Reference LabJW Grand Ballroom I

Title: Small Fiber Neuropathy: From Density to Clarity. Incorporating a Diagnostic Algorithm

Presenter: Dr. Todd Levine

10:00 am - 12:00 pm

Session


Discuss the key considerations related to developing upper extremity exoskeleton technology and designing the technology for patients with NMDs like DMD; recognize current capabilities and future applications of these technologies; discuss the current state of integrated brain-computer applications for patients with NMDs.

10:00 am: Welcome Anthony E. Chiodo, MD, MBA

10:05 am: ANF International and IFCN Scholarships Anthony E. Chiodo, MD, MBA

10:10 am: President's Research Initiative Awards Anthony E. Chiodo, MD, MBA

10:20 am: Introduction Anthony E. Chiodo, MD, MBA

10:25 am: Key Considerations for Upper Extremity Exoskeleton Technology Development for Individuals With Duchenne Muscular Dystrophy and the Importance of User-Centered Design Madeline Corrigan, PhD


11:10 am: Brain-Computer Interface Applications for Individuals with NM Diseases Dennis McFarland, PhD

2.0 CME/CEU11:40 am: Closing Anthony E. Chiodo, MD, MBA


Thank you for your service and dedication to the pursuit of quality patient care.

American Board of Electrodiagnostic Medicine (ABEM)

2018-2019Board of Directors

John England, MD, ChairMichael T. Andary, MD, Vice Chair

Francis Walker, MD, SecretaryChristina Marciniak, MD, Treasurer

MembersPeter A. Grant, MDJanice Massey, MD

Timothy R. Dillingham, MDKathleen Kennelly, MD

12:00 pm - 1:15 pm

IndustryForum


An Expert Conversation: From ALS Diagnosis to Treatment

Sponsored by: Mitsubishi Tanabe Pharma America, Inc.

Please join Mitsubishi Tanabe Pharma America, Inc. for a stimulating discussion on the diagnosis and treatment of ALS moderated by Dr. Carlayne Jackson.

Presenter: Carlayne Jackson, MDProfessor of Neurology and OtolaryngologyUniversity of Texas Health Science Center San Antonio, Texas

This activity is sponsored by Mitsubishi Tanabe Pharma America, Inc. and is not part of the official scientific program of AANEM.



No CME/CEU

1:00 pm - 1:30 pm

Social Event

Abstract Poster Session IGriffin Hall

Authors of abstracts 1-127 will be available to discuss their research. Stop by to review the information from this year’s abstracts and meet the authors.

1:30 pm - 3:00 pm

Session

Combined Use of EDX & US for Evaluation of the Brachial Plexus & Upper Limb Nerves - Part 1Lone Star D

Examining the upper limbs and brachial plexus, identify how to use high frequency US to image the PNS; articulate the importance of the EDX evaluation; state the strength and weaknesses of using US and EDX; and make improved management decisions for your patients. Challenging Cases will be presented in this session.


1:30 pm: Intoduction Jeffrey A. Strakowski, MD

1:35 pm: Live Demonstrations of US of the Brachial Plexus and Nerves of the Upper Limb Jeffrey A. Strakowski, MD

1.5 CME/CEU

2:15 pm: EDX Evaluation of the Brachial Plexus and Upper Limb Nerves Jun Kimura, MD


1:30 pm - 3:00 pm

Session

Updates of Demyelinating Neuropathies: Jointly Provided by AANEM & PNS Lone Star E

Related to CIDP, articulate issues with making a reliable diagnosis; implement optimal use of IVIG in patients; and appraise future immunotherapies that may be used in the management of this disease.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AANEM and the Peripheral Nerve Society. The AANEM is accredited by the ACCME to provide continuing medical education for physicians.


1:30 pm: Introduction Shawn J. Bird, MD

1:35 pm: Challenges in the Diagnosis of CIDP Jeffrey A. Allen, MD

2:00 pm: The Proper Use of IVIG in CIPD David R. Cornblath, MD

2:25 pm: Future Treatments for CIDP: Beyond IVIG and Corticosteroids Mazen M. Dimachkie, MD


1:30 pm - 3:00 pm

Session

Autonomic Disorders in Your NM Practice: How to Identify and Treat Them - Part 1Lone Star G-H

Identify peripheral autonomic disorders in a typical NM practice, encompassing diabetic, amyloid, autoimmune autonomic neuropathy, and those associated with small fiber neuropathy; correctly interpret testing; identify patterns per disease, and provide patients with available treatments including for orthostatic hypotension.

1:30 pm: Introduction Amanda C. Peltier, MD, MS

1:35 pm: Basic Autonomic Testing: Pearls and Pitfalls Jasvinder P. Chawla, MBBS, MD, MBA

1.5 CME/CEU2:45 pm: Peripheral Autonomic Disorders Steven Vernino, MD, PhD

1:30 pm - 3:00 pm

Session

Emerging Therapies and Controversies Lone Star A-B

Articulate the emerging treatments and controversies in DMD, including exon skipping, newer generation steroids and gene replacement; appraise novel therapies and advances in CIDP therapy, nodal and paranodal antibodies therapy and complement inhibition in GBS; and recommend the most impactful therapies and mechanisms to optimize treatment for hereditary metabolic myopathies in 2019.

1:30 pm: Introduction Bassam A. Bassam, MD

1:35 pm: Novel Therapies in Immune-Mediated Neuropathies Mazen M. Dimachkie, MD

2:00 pm: Treatments for Hereditary Metabolic Myopathies in 2019 Margherita Milone, MD, PhD

2:25 pm: Emerging Treatments and Controversies in the Treatment of Duchenne Muscular Dystrophy Perry B. Shieh, MD, PhD



1:30 pm - 3:00 pm

Session

Axonal Peripheral Neuropathy (Toxic and Metabolic)Lone Star C

Describe the spectrum of neuropathies seen in CIPN, inflammatory/immune diabetic neuropathies, and axonal neuropathies as well as the presentations of these diseases; be able to evaluate the patient and interpret NCSs; develop a treatment plan and management approach; and develop an approach to determine whether a diabetic has superimposed CIDP.

1:30 pm: Introduction Benn E. Smith, MD

1:35 pm: Chemotherapy Induced Peripheral Neuropathy Mark B. Bromberg, MD, PhD

2:00 pm: The Challenges in Making Sense of Diabetic and Inflammatory Neuropathies Richard A. Lewis, MD

2:25 pm: Clinical Aspects of Axonal Neuropathy Benn E. Smith, MD


1:30 pm - 3:00 pm

Session

Neuromuscular PathologyBrazos

Identify the usefulness of nerve and muscle biopsies in era of genetics testing; integrate the findings with the clinical evaluation; and formulate the treatment based on the results in complex/unusual NM cases.

1:30 pm: Introduction Justin Y. Kwan, MD

1:35 pm: Utility of Nerve and Muscle Biposy Justin Y. Kwan, MD

2:00 pm: Unusual Nerve and Muscle Cases Suur Biliciler, MD

2:25 pm: Unusual Nerve and Muscle Cases Cecile L. Phan, MD


1:30 pm - 3:00 pm

Session

NM Complications of Cancer Treatment With Checkpoint Inhibitors and ChemotherapyLone Star F

Articulate the common presentations of CIPN; recognize the diagnostic conundrums that arise in the care of cancer patients with new neuropathies; apply CIPN guidelines directly to patient care; recognize when a NM complication of immune checkpoint inhibitor (ICPI) therapy should be on the differential diagnosis; conduct an appropriate work up; summarize therapeutic options; and recognize when and how to access specific expertise for challenging cases of ICPI complications.

1:30 pm: Introduction Noah A. Kolb, MD

1:35 pm: Chemotherapy Induced Peripheral Neuropathy: A Practical Guide to Diagnosis, Treatment, and Diagnostic Conundrums Noah A. Kolb, MD

2:00 pm: What You Need to Know About NM Complications of Checkpoint Inhibitors and Other Immune Cancer Therapies Christopher Trevino, MD

2:25 pm: What You Need to Know About the NM Complications of Checkpoint Inhibitors and Other Immune Cancer Therapies Amanda C. Guidon, MD


3:00 pm - 4:00 pm

Social Event



3:10 pm - 3:30 pm

Session

Presentation Stage by AlexionJW Grand Ballroom I

Title: A Treatment for Adult Patients with Anti-Acetylcholine Receptor (AChrR) Antibody Positive Generalized Myasthenia Gravis (gMG)

Presenter: Dr. Todd Levine


Share Your AANEM Annual Meeting Experience on Social Media!

Use the Hashtag: #AANEMinAUSTIN

3:30 pm - 4:00 pm

Social Event

Abstract Poster Session IIGriffin Hall


3:40 pm - 4:00 pm

Session

Presentation Stage by Nihon KohdenJW Grand Ballroom I

Title: F-waves

Presenter: Dr. Jun Kimura

No CME/CEU

4:00 pm - 5:30 pm

Session

Combined Use of EDX & US for Evaluation of the Brachial Plexus & Upper Limb Nerves - Part 2Lone Star D

Examining the upper limbs and brachial plexus, identify how to use high frequency US to image the PNS; articulate the importance of the EDX evaluation; state the strength and weaknesses of using US and EDX; and make improved management decisions for your patients. Challenging Cases will be presented in this session.


4:00 pm: Neuromuscular Ultrasound for Upper Extremity Focal Neuropathies Michael S. Cartwright, MD

4:45 pm: Case Discussions Jeffrey A. Strakowski, MD


4:00 pm - 5:30 pm

Session

Diagnosis and Treatment Breakthroughs in Genetic Testing Lone Star E

Integrate current testing platforms in your neuropathy practice; state technical strengths and limitations of next generation sequencing testing for various forms of neuropathy; articulate the new treatment and research approaches afforded by genetic testing; illustrate importance of correlating molecular findings with clinical and other laboratory data; convey the relevance of a genetic diagnosis for proper treatment; evaluate hereditary myopathies and neurogenic processes sharing the same defective gene; assess genetic technical analysis strategies and genetic counseling; produce comprehensive genetic testing reports by applying evidence-based gene variant classification guidelines; and articulate the latest advances in population genomic-driven drug discovery.


4:00 pm: Small Molecule Therapies in Neurogenic Disease Christopher J. Klein, MD

4:25 pm: The Landscape of Therapy in Hereditary Myopathies Margherita Milone, MD, PhD

4:50 pm: Genome Editing Technologies and Neuromuscular Disease Nicolas Madigan, MD



4:00 pm - 5:30 pm

Session

Autonomic Disorders in Your NM Practice: How to Identify and Treat Them - Part 2Lone Star G-H

Identify peripheral autonomic disorders in a typical NM practice, encompassing diabetic, amyloid, autoimmune autonomic neuropathy, and those associated with small fiber neuropathy; correctly interpret testing; identify patterns per disease, and provide patients with available treatments including for orthostatic hypotension.

4:00 pm: How to Treat Autonomic Disorders Amanda C. Peltier, MD, MS

4:45 pm: Discussion and Q & A Jasvinder P. Chawla, MBBS, MD, MBA

4:45 pm: Discussion and Q & A Steven Vernino, MD, PhD

1.5 CME/CEU4:45 pm: Discussion and Q & A Amanda C. Peltier, MD, MS

4:00 pm - 5:30 pm

Session

Traumatic Brachial PlexopathyBrazos

Identify the anatomy of the brachial plexus and clinical presentations of traumatic brachial plexopathies; convey how EDX studies can localize and quantify the degree of injury and prognosis; assess imaging studies including MRI neurography, CT myelogram, and US; compare the Seddon and Sunderland grading systems and how MRI neurography can help predict pre-operative injury grade; articulate intraoperative modalities (CMAP, NAP) employed for brachial plexus surgeries and how IOM helps guide surgical options; and identify cutting edge surgical options, including neurolysis, nerve grafting and transfer.

4:00 pm: Introduction Vita G. Kesner, MD, PhD

4:05 pm: Traumatic Brachial Plexopathies; Clinical Manifestations and Electrophysiological Modalities Vita G. Kesner, MD, PhD

4:25 pm: Multimodality Imaging of Brachial Plexus Trauma Adam Singer, MD

4:50 pm: Current Surgical Approaches for Restoration of Upper Extremityfunction and Outcomes Nicholas M. Boulis, MD


4:00 pm - 5:30 pm

Session

MUAP Recruitment Analysis Made SimpleLone Star C

Recognize MUAP firing rates with a high degree of accuracy; formulate recruitment ratios using auditory recognition skills; and assess whether recruitment is normal or abnormal in a variety of examples.


4:00 pm: Introduction & Overview of MUP Recruitment Concepts and Recognition Skills Devon I. Rubin, MD

4:30 pm: Learning to Recognize Firing Rates Devon I. Rubin, MD

4:45 pm: Determining Recruitment Ratios Devon I. Rubin, MD

1.5 CME/CEU5:00 pm: Quiz: Assessing recruitment of unknown examples Devon I. Rubin, MD

4:00 pm - 5:30 pm

Session

Member Practice Issues Open ForumRoom 401

The Professional Practice Committee (PPC) will be hosting an open forum for members to discuss any current issues or trends they are seeing in their practices and that the PPC may be able address either with advice, or potentially, through the creation of a new position statement.

No CME/CEU


AANEM Product StoreSave on select educational products while supplies last!

Stay up-to-date on your neuromuscular and electrodiagnostic medicine with our collection of books, DVDs, self-assessments, and interactive

products. Come visit us at AANEM Product Store located in the JW Grand Ballroom Foyer.

4:00 pm -5:30 pm

Session

NeuroprostheticsLone Star F

Identify and discuss the clinical implications of direct neural control for powered upper limb prostheses via regenerative peripheral nerve interfaces (RPNI) as well as the clinical application of RPNIs in the management and prevention of limb pain in individuals with limb loss.

4:00 pm: Introduction Gregory Robbins, MD

4:05 pm: Case Presentation, Upper Limb Prosthetic Control: The Need James A. Leonard, MD

4:10 pm: Using Regenerative Peripheral Nerve Interfaces for Real-Time Prosthetic Finger Control Cynthia Chestek

4:40 pm: Case Presentation, Neuroma Pain: The Problem James A. Leonard, MD

4:45 pm: Regenerative Peripheral Nerve Interfaces for the Treatment and Prevention of Postamputation Pain Theodore Kung

5:15 pm: Case Presentation, Neuroma Pain: The Outcome James A. Leonard, MD


5:45 pm - 6:45 pm

Social Event

Abstract Award Winners' ReceptionLone Star Ballroom Foyer

Enjoy an evening celebrating research! Socialize with colleagues and abstract authors while enjoying complimentary food, wine, beer and other refreshments. Best Abstract and President's Research award-winning authors will be available for discussion of their research.

5:45 pm - 6:45 pm

Social Event



7:00 pm - 9:00 pm

Social Event

EMG TalkLone Star G-H

Spike and Wave are BACK! Join Drs. Bill Litchy and Larry Robinson for a return performance of the long standing EMG Talk! Enjoy a good laugh while learning too. Audience participation is key. Prizes will be awarded. Sweet Treats, alcoholic and nonalcoholic beverages will be served.

Sponsored by Natus Neuro

4:00 pm -5:30 pm

Session










5:45 pm - 6:45 pm

Social Event



5:45 pm - 6:45 pm

Social Event



7:00 pm - 9:00 pm

Social Event




4:00 pm -5:30 pm

Session










5:45 pm - 6:45 pm

Social Event



5:45 pm - 6:45 pm

Social Event



7:00 pm - 9:00 pm

Social Event




35 Friday | October 18

6:45 am - 8:00 am

IndustryForum


A Therapy for the Polyneuropathy of hATTR Amyloidosis in Adults

Sponsored by: Alnylam Pharmaceuticals

Session Description: This program will provide an overview of hereditary transthyretin-mediated (hATTR) amyloidosis, discuss prevalence, review red-flag symptoms of the disease, and describe the clinical data and product characteristics of the first ever FDA approved RNAi therapeutic for the treatment of the polyneuropathy of hATTR amyloidosis in adult patients.

Presenter: Thomas H. Brannagan III, MDProfessor of NeurologyColumbia University Medical CenterDepartment of Neurology

Co-Director, EMG LaboratoryNew York-Presbyterian Hospital Columbia Campus

This activity is sponsored by Alnylam Pharmaceuticals and is not part of the official scientific program of AANEM.



No CME/CEU

7:30 am - 4:00 pm

Social Event

Poster HallGriffin Hall

Take time to stroll through the Poster Hall to view research submitted for the annual meeting. Poster authors will be available at specified times to discuss their research.

8:00 am - 9:30 am

Session

N of 1 Trials to Personalize TreatmentRoom 309

Recommend when and how N-of-1 trials can be conducted to obtain a more precise and personalized treatment outcome in comparison to the standard "trial of treatment" used in daily clinical practice.

This is an "Ask the Experts" session. There will be an interactive discussion designed around audience participation. There are no handouts nor a planned presentation and this session will not be included in the Annual Meeting Collection.

1.5 CME/CEU Bas Stunnenberg, MD

8:00 am - 9:30 am

Session

Peripheral NeuropathyRoom 308

Articulate a differential diagnosis of peripheral neuropathy; arrange neuropathies into motor, sensory, and mixed types as well as into demyelinating and axon loss types; assess EDX approach to evaluating patients with diffuse polyneuropathies; and implement treatment options from immunosuppression to neuropathic pain management.


1.5 CME/CEU Peter D. Donofrio, MD

8:00 am - 9:30 am

Session

NMJ TechniquesRoom 302

Articulate NMJ physiology; evaluate RNS testing techniques, quality control, and findings in disease; illustrate jitter assessment with single-fiber and concentric needles; and improve EDX assessment for patients with NM transmission disorders.


1.5 CME/CEU Amanda C. Guidon, MD

36Friday | October 18

8:00 am - 9:30 am

Session

Brachial PlexopathiesRoom 304

Articulate brachial plexus anatomy; illustrate the role of the sensory and motor NCSs to localize and characterize the lesions (pathophysiology, severity, prognosis); use needle EMG to add to the NCS findings, especially its temporal features (slowly progressive, rapidly progressive, acute, subacute, chronic). Cases will be used to demonstrate how to improve patient care.


No CME/CEU Mark A. Ferrante, MD

8:00 am - 9:30 am

Session

What Reference Values and NCS Techniques Should I Use in My PracticeRoom 307

State how high quality normative data (reference values) is derived; for common NCSs, use techniques and reference values created by the Normative Data Task Force; and incorporate the data into your practice to improve patient care.


1.5 CME/CEU Timothy R. Dillingham, MD, MS

8:00 am - 9:30 am

Session

EDX Evaluation of the FootRoom 310

In an EDX evaluation of the foot, design the optimal EDX evaluation; state the role of needle EMG; and generate a differential diagnosis for neuropathic foot pain, including entrapment neuropathies in the foot/ankle.


1.5 CME/CEU David R. Del Toro, MD

8:00 am - 9:30 am

Session

Cranial Nerve TestingRoom 311

Identify basic anatomy and physiology which underlie testing of trigeminal, facial, spinal accessory and hypoglossal nerves; recognize single and repetitive nerve stimulation techniques used to study facial and spinal accessory nerves to evaluate weakness; articulate principles and pitfalls of blink reflex studies to assess trigeminal and facial nerves; identify characteristics of EMG abnormalities in patients with facial weakness; and apply skills of EMG for rational evaluation of cranial nerve function and dysfunction.


1.5 CME/CEU Jun Kimura, MD

8:00 am - 9:30 am

Session

Ethical Issues in NM DiseaseRoom 301

Interpret “Right-to-Try” laws regulating the use of drugs not yet approved by the FDA for prescribing and recognize how drug manufacturers balance the need to make a profit versus drug affordability by individuals and society.


1.5 CME/CEU Zachary Simmons, MD


2020Don’t miss next year’s AANEM Annual Meeting

Orlando, Florida | Oct. 7-10, 2020

8:00 am - 9:30 am

Session

Entrapment NeuropathiesRoom 306

Demonstrate how to use the Robinson Index for diagnosis of CTS; identify the best approaches for diagnosing ulnar neuropathy at the elbow; and convey how to formulate prognostic statements in focal neuropathies.


1.5 CME/CEU Lawrence R. Robinson, MD

8:00 am - 9:30 am

Session

Basics With the ExpertsLone Star E

Articulate the basic concepts underlying nerve conduction and approach to the study; conduct and interpret NCSs in the upper and lower extremities and identify anomalous innervations; use specialized studies including RNS, cranial nerve studies, and blink reflex; and apply needle EMG for the diagnosis of NM disorders.

8:00 am: Introduction Mohammad K. Salajegheh, MD

8:05 am: Nerve Conduction Basics & Approach to Study Mohammad K. Salajegheh, MD

8:25 am: Nerve Conduction Study Methods Kelly G. Gwathmey, MD

8:55 am: Needle EMG Basics and Specialized Studies Aaron Izenberg, MD


8:00 am - 9:30 am

Session

Fascicular Anatomy of the Nerve and Nerve Injuries Updated With Ultrahigh Frequency MSK USLone Star D

Revisit the fascicular anatomy of the nerve from 50 years history by Sydney Sunderland with high frequency US techniques.

8:00 am: Introduction Elizabeth G. Forrest, MD

8:05 am: Nerve and Nerve Injuries, Sunderland : 50 years later Faye Y. Tan, MD

8:35 am: Live Demo of Ultra High Frequency US for Assessment of Peripheral Nerve Anatomy and Focal Neuropathies Jeffrey A. Strakowski, MD


8:00 am - 9:30 am

Session

Setting Up an US LabLone Star F

Related to NM US, recognize the equipment needed; assess implementation barriers in EMG laboratories; implement appropriate coding; and recognize the need for appropriate training.

1.5 CME/CEU8:00 am: Setting us a US Lab Lisa D. Hobson-Webb, MD


8:00 am - 9:30 am

Session

The Use of Multiple Testing Modalities in Challenging NM CasesLone Star B

Identify less frequently used testing modalities to aid in the diagnosis and management of patients with NMDs; recognize the clinical significance of less commonly used blood tests; articulate basics of muscle MRI and its role in diagnostic testing and as a treatment outcome measure; appraise the clinical indication of various types of genetic testing and identify less commonly used molecular testing modalities; apply information learned to challenging cases where routine tests could not determine a diagnosis.

8:00 am: Introduction Elie Naddaf, MD

8:05 am: Just a Blood Test: Antibodies and Other Laboratory Testing Rami Massie, MD, CM

8:30 am: How EDX and Genetic Testing Can Complement Each Other Peter B. Kang, MD

8:55 am: The Use of Muscle MRI in Clinical Practice Elie Naddaf, MD


8:00 am - 9:30 am

Session

Exercise for NM DiseaseLone Star A

Appraise the acquired and hereditary disorders of muscle, specifically those associated with high CK; manage patients with regard to activity in the setting of high CK and the underlying disease; and articulate how patients can maintain maximal function in the setting of progressive muscle disease.

8:00 am: Introduction Anne G. Hartigan, MD

8:05 am: Exercise in Disorder of Muscle Ann A. Little, MD

8:30 am: Exercise in Post-Polio Syndrome: Walking the Line Ann T. Laidlaw, MD

8:55 am: Exercise in Diabetic Neuropathy Anne G. Hartigan, MD


8:00 am - 9:30 am

Workshop

W33FA You Make the Call: An Interactive Approach to EMG Waveform Recognition Skills-BASIC

Identify the firing patterns of different types of EMG waveforms; identify the characteristics of a variety of normal and abnormal spontaneous waveforms; recognize normal and abnormal patterns of recruitment of MUAPs; and recognize and understand the significance of the changes in morphology of MUAPs in diseases. Includes audience participation and videos of EMG waveforms.

This is a large group workshop open to physicians only.

1.5 CME Devon I. Rubin, MD

8:00 am - 9:30 am

Workshop

W83R Intro. to NM US Anatomy-Resident/Fellow

Limited to residents/fellows and medical students only. Topics covered will include US devices and equipment, how to incorporate US into a busy EDX laboratory, how to image muscle, how to image nerve, and how to assess for the following potential conditions: CTS, ulnar neuropathy at the elbow, ulnar neuropathy at the wrist, and fibular neuropathy at the knee. As time permits, the assessment of other NM conditions will be addressed.


Sarada Sakamuri, MD

No CME/CEU Michael S. Cartwright, MD

9:00 am - 4:00 pm

Social Event

Exhibit HallJW Grand Ballroom



9:30 am - 10:00 am

Social Event



9:40 am - 10:00 am

Session


Title: History of Single Fiber EMG

Presenter: Dr. Bashar Katirji

No CME/CEU

10:00 am - 12:00 pm

Session


Discuss the complexities of human-machine interfaces and be able to recognize the uses of regenerative peripheral nerve interfaces for control of neuroprosthetic devices and how robotics can improve the lives of patients with NMDs; recognize the complexities of the application process for emerging robotic technology for human use; and discuss the current state and future considerations for lower extremity robotics in mobility applications for patients with NMDs.


10:05 am: Awards: Lifetime Achievement, Distinguished Physician, Jun Kimura Outstanding Educator, Ernest Johnson Outstanding Educator, Innovation, Distinguished Researcher, Scientific Impact (PMR & Neurology), and Advocacy Timothy R. Dillingham, MD, MS


10:25 am: Use of Regenerative Peripheral Nerve Interfaces for Control of Neuroprosthetic Devices Paul Cederna, MD


11:05 am: Future of Rehabilitation Robotics and Practice Arun Jayaraman, PT, PhD


10:00 am - 4:00 pm

Social Event

Silent Auction Winner Pick-upJW Grand Ballroom Foyer

Silent Auction winners, pick-up your items at the Registration Booth.

12:00 pm - 1:15 pm

IndustryForum


Why LEMS in Adults Warrants a Closer Look: Clinical Insights and Common Misdiagnoses

Sponsored by: Catalyst Pharmaceuticals, Inc.

This session will delve into the diagnosis and treatment of Lambert-Eaton myasthenic syndrome (LEMS). As LEMS in adults is often misdiagnosed, leading to a delay in diagnosis, we’ll focus on differentiating LEMS from similar neuromuscular conditions using current diagnostic recommendations. We’ll also discuss therapeutic approaches that can minimize patients’ symptoms and increase muscle strength, with insight into: • Recent studies that led to the FDA approval of FIRDAPSE® (amifampridine) for the treatment of LEMS in adults and answers to frequently asked questions or misunderstandings• An update on the services and support offered by Catalyst to ensure that all adult LEMS patients have access to treatment

Presenters: Perry Shieh, MD, PhD UCLA David Geffen School of Medicine

Stanley Iyadurai, MD, PhD Catalyst Pharmaceuticals, Inc.

This activity is sponsored by Catalyst Pharmaceuticals, Inc. and is not part of the official scientific program of AANEM.



No CME/CEU


1:00 pm - 1:30 pm

Social Event

Abstract Poster Session IIIGriffin Hall


1:30 pm - 3:00 pm

Session

Horses, Zebras, & Unicorns: Interactive Case Based Update Common/Not So Common NMDs-Pt 1Lone Star G-H

As it relates to common and unusual nerve and muscle disorders, articulate clinical characteristics of these disorders; recognize the role of EDX testing, genetic testing, serological studies, and biopsy for diagnosing and evaluating patients; and utilize PNS anatomy to help facilitate clinical evaluation and treatment in complex patients.

1:30 pm: Introduction Justin Y. Kwan, MD

1:35 pm: A Clinical and Diagnostic Approach to Muscular Dystrophies Mithila Vullaganti, MD

1.5 CME/CEU2:20 pm: Diagnosis and Treatment of Inflammatory Myopathies Suur Biliciler, MD

1:30 pm - 3:00 pm

Session

Peripheral Anatomy: From Root to MuscleLone Star D

List upper and lower limb anatomy beginning at the nerve root level and continuing down to the muscle and recognize the presentation of common abnormalities using NCSs.

This is a Self-Assessment (SA) CNCT Checkpoint session. To receive the SA CNCT Checkpoint credit, a post-test must be completed with a 70% passing rate. Post-tests are free to members and $50 for nonmembers.

1:30 pm: Introduction Loretta M. VanEvery, MD

1:35 pm: Nerve Root and Plexus Adam D. Comer, MD

2:00 pm: Peripheral Nerve Jerry Morris, CNCT, MS, R.NCS.T.

2:25 pm: NMJ and Muscle Tristin Allen, MD


1:30 pm - 3:00 pm

Session

ALSLone Star B

As it relates to ALS, assess the status of biomarkers; identify the diagnostic features of EMG; and appraise the newest treatment options and developments.


1:30 pm: Introduction Eric J. Sorenson, MD

1:35 pm: Pathophysiology and Biomarkers in ALS Nathan P. Staff, MD, PhD

2:00 pm: Making the Diagnosis Jennifer M. Martinez-Thompson, MD

2:25 pm: Current Practices in ALS Management and Clinical Trials Bjorn E. Oskarsson, MD

1.5 CME/CEU

2:50 pm: Learn How the National ALS Registry Advances Research Paul Mehta, MD


The No. 1 place for your PMR andNM/EDX job search!

Explore the career center today atwww.healthecareers.com/aanem

1:30 pm - 3:00 pm

Session

US Assessment of MSK MimicsLone Star E

Identify common MSK conditions that could clinically mimic focal neuropathies; distinguish peripheral nerve and MSK pathology; and identify through clinical cases using US and EDX how to distinguish potential MSK abnormalities from focal neuropathies.

1.5 CME/CEU1:30 pm: US Assessment of MSK Mimics Jeffrey A. Strakowski, MD

1:30 pm - 3:00 pm

Session

NMJ Disorders - Part 1Lone Star C

Regarding NMJ disorders, identify the clinical manifestations of both presynaptic (Lambert-Eaton myasthenic syndrome and botulism) and postsynaptic (myasthenia gravis) disorders; articulate the diagnostic approach including laboratory and EDX testing (specifically RNS testing and single fiber EMG); and apply the treatment approach.


1:30 pm: Introduction to NMJ Disorders (Clinical Presentations) Kelly G. Gwathmey, MD

1.5 CME/CEU2:15 pm: Electrodiagnostic Approach to NMJ Disorders Hans D. Katzberg, MD

1:30 pm - 3:00 pm

Session

Albers SymposiumLone Star A

After attending the session the attendee will be able to describe different classes of neuropathy; utilize electrophysiology and skin biopsy to diagnose these diseases; and develop optimal treatment plans for their patients.

1:30 pm: Introduction: Early Stories Anthony G. Alessi, MD

1:40 pm: CIDP Peter D. Donofrio, MD

1:50 pm: Costs of CIDP Mark B. Bromberg, MD, PhD

2:00 pm: Paraproteinemc Neuropathies Zachary Simmons, MD

2:10 pm: Albers and DCCT Eva L. Feldman, MD, PhD

2:20 pm: Other Complications of Diabetes (Autonomic, Gastroparesis) Safwan S. Jaradeh, MD

2:30 pm: Prediabetes, Metabolic Syndrome, Obesity and Neuropathy: Where We are Today John R. Singleton, MD

2:40 pm: Exercise and Diabetic Neuropathy A. Gordon Smith, MD

2:50 pm: Myelinated Fibers in Diabetes Amanda C. Peltier, MD, MS

No CME/CEU3:00 pm: Decompressive Surgery in Diabetes Ryan D. Jacobson, MD


1:30 pm - 3:00 pm

Session

ROUNDTABLE: Case DiscussionsRoom 301-302

Confer with experts in a smaller one-on-one setting to improve your performance and interpretation of clinical studies and add clinical input. This session will improve your use of quality EDX studies in the diagnosis and treatment of patients. Participants are encouraged to bring their own cases to the session.

Limited to 60 - registration is required.

1:30 pm: Case Discussions Bashar Katirji, MD

1:30 pm: Case Discussions Erik R. Ensrud, MD

1:30 pm: Case Discussions Bryan E. Tsao, MD

1:30 pm: Case Discussions David C. Preston, MD

1:30 pm: Case Discussions Mark A. Ferrante, MD

1.5 CME/CEU1:30 pm: Case Discussions Said R. Beydoun, MD

1:30 pm - 3:00 pm

Workshop

W27R Repetitive Nerve Stimulation-Resident/Fellow

Limited to residents/fellows and medical students only. Participants will perform RNS to shoulder, upper arm, hand, and facial muscles; and perform sequential examination for detecting NM transmission defects, such as artifacts.


No CME/CEU Taylor B. Harrison, MD

1:30 pm - 3:00 pm

Workshop

W33FC You Make the Call: An Interactive Approach to EMG Waveform Recognition Skills-ADVANCED

Identify the characteristics of a variety of uncommon abnormal spontaneous waveforms; recognize normal and abnormal patterns of recruitment of MUAPs; and recognize and understand the significance of subtle or complex changes in morphology of MUAPs in diseases. The workshop includes audience participation and video examples of EMG waveforms.

1.5 CME Devon I. Rubin, MD

3:00 pm - 4:00 pm

Social Event



3:10 pm - 3:30 pm

Session


Title: The Statistically Correct Approach to the Use of Nerve Conduction Studies in Carpal Tunnel Syndrome

Presenter: Dr. David Preston

No CME/CEU

3:30 pm - 4:00 pm

Social Event

Abstract Poster Session IVGriffin Hall



4:00 pm - 5:30 pm

Session

Upper Extremity NCS: Lesion Localization and Severity AssessmentLone Star D

List upper extremity anatomy, including the brachial plexus; recognize lesion patholphysiology (through NCS); localize lesions and through formulas make severity assessments. A case based approach will be utilized.


1.5 CME/CEU

4:00 pm: Upper Extremity NCS: Lesion Localization and Severity Assessment Mark A. Ferrante, MD

4:00 pm - 5:30 pm

Session

Horses, Zebras, & Unicorns: Interactive Case Based Update Common/Not So Common NMDs-Pt 2Lone Star G-H

As it relates to common and unusual nerve and muscle disorders, articulate clinical characteristics of these disorders; recognize the role of EDX testing, genetic testing, serological studies, and biopsy for diagnosing and evaluating patients; and utilize PNS anatomy to help facilitate clinical evaluation and treatment in complex patients.

4:00 pm: Introduction Dustin Nowacek, MD

4:05 pm: Identification of Treatable Neuropathies Gary W. Gallagher, MD

4:45 pm: Plexopathy Cases, Complex and Perplexing Ryan D. Jacobson, MD


4:00 pm - 5:30 pm

Session

NMJ Disorders - Part 2Lone Star C

Regarding NMJ disorders, identify the clinical manifestations of both presynaptic (Lambert-Eaton myasthenic syndrome and botulism) and postsynaptic (MG) disorders; articulate the diagnostic approach including laboratory and EDX testing (specifically RNS testing and single fiber EMG); and apply the treatment approach.


4:00 pm: Treatment of NMJ Disorders Amanda C. Guidon, MD

1.5 CME/CEU4:45 pm: NMJ Disorder Cases Michael K. Hehir, MD

4:00 pm - 5:30 pm

Session

Single Fiber EMG CourseLone Star E

Compare the use of SFEMG and concentric needle electrodes (CNE) to measure jitter; recognize signals that should/should not be used to measure jitter with CNE; interpret jitter measurements in patients with suspected NMJ disorders; convey the utility and sensitivity of jitter studies in patients with suspected NMJ disorders; and recognize when abnormal jitter does not represent NMJ disease.

4:00 pm: Introduction Donald B. Sanders, MD

4:05 pm: Jitter - What Is It, and How Is It Measured? Donald B. Sanders, MD

4:30 pm: Jitter in MG Janice M. Massey, MD

5:00 pm: Pitfalls & Errors in Measuring Jitter Donald B. Sanders, MD



4:00 pm - 5:30 pm

Session

Assistive Technology for Gait DisorderLone Star B

Identify common gait deviations in NMDs and appropriate orthotic prescriptions; assess the innovative technologies available and in development, such as robotics and exoskeletons, that can be used to improve gait pathology; and recognize opportunities for research in gait assistive technology.

4:00 pm: Orthotic Devices in Neuromuscular Gait Disorders William Filer, MD

4:40 pm: Frontiers in Wearable Technology: Robotics & Sensor Technology Arun Jayaraman, PT, PhD

1.5 CME/CEU5:20 pm: Discussion and Q&A

4:00 pm - 5:30 pm

Session

Channelopathies in NMDsLone Star A

Appraise the clinical presentations, genetics, and treatment of periodic paralysis; distinguish between sub-types of periodic paralysis on clinical grounds (history, specific triggers, etc.) and articulate prophylactic treatments and potential pitfalls; and recognize when and how to perform an ancillary examination (ictal serum potassium, EMG, genetics) when evaluating a patient with periodic paralysis.

4:00 pm: Introduction Jau-Shin Lou, MD, PhD, MBA

4:05 pm: Episodic Ataxias Jau-Shin Lou, MD, PhD, MBA

4:40 pm: Periodic Paralysis Bas Stunnenberg, MD


4:00 pm - 5:30 pm

Session

Practical Approach to EDX in the Pediatric PopulationLone Star F

Apply EDX successfully in infants and children with little or no sedation; compare how the interpretation of specific EDX findings differs in pediatric versus adult patients; and articulate how EDX can guide the diagnostic evaluation of rare genetic disorders in the pediatric population.

4:00 pm: Introduction Peter B. Kang, MD

4:05 pm: Technical Approaches to EDX in Infants and Children Peter B. Kang, MD

4:30 pm: Nuances of EDX Interpretation in Pediatrics Hugh J. McMillan, MD

4:55 pm: The Use of EDX to Diagnosis Rare Genetic Disorders Tanya J. Lehky, MD


5:30 pm - 6:30 pm

Social Event

Happy HourLone Star Ballroom Foyer

Enjoy live music, refreshments, and socializing with friends and colleagues. Attend the last social event of this year’s annual meeting to celebrate another successful meeting and say farewell until next year!

5:30 pm - 6:30 pm

Social Event



5:30 pm - 6:30 pm

IndustryForum


Current Approaches to Multifocal Motor Neuropathy: What Every Clinician Should Know

Sponsored by: Shire, now part of Takeda

Multifocal motor neuropathy (MMN) is an acquired immune-mediated peripheral neuropathy. This slowly progressive disorder is characterized by asymmetric and distal weakness and wasting but


Training Program

PartnershipJoin the TPP for just $253!

Free AANEM membership for residents/fellows

Exclusive educational materials

Deep discounts on the AANEM Annual Meeting

Access to all the services of AANEM

without sensory impairment. MMN may lead to severe disability and has been associated with devastating impacts on patient daily function and quality of life. This symposium takes an interactive, case-based approach to the management of MMN, presenting participants with the opportunity to review and discuss therapeutic options within a range of patient presentations that mirror clinical practice. Expert-led presentations and discussions will reflect on pathophysiology of MMN, diagnosis, and management using personalized therapy.

Presenter(s):Richard A. Lewis, MDChair, Cedars-Sinai Medical Center Los Angeles, California

Mark B. Bromberg, MD, PhDPanelistProfessor of Neurology University of Utah Salt Lake City, Utah

Jonathan Katz, MDPanelistCalifornia Pacific Medical Center Research Institute San Francisco, California

For Physicians:Medscape, LLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is sponsored by Shire, now part of Takeda and is not part of the official scientific program of AANEM.



No CME/CEU

46Saturday | October 19

8:00 am - 9:30 am

Session

Demyelinating NeuropathiesLone Star G-H

Convey the criteria for identifying demyelination on NCS and articulate the presentation, diagnosis, and treatment of GBS and CIDP.


8:00 am: Introduction Shawn J. Bird, MD

8:05 am: Electrodiagnostic Criteria of Demyelination Shawn J. Bird, MD

8:30 am: Guillain-Barre Syndrome Christyn Edmundson, MD

8:55 am: Chronic Inflammatory Demyelinating Polyneuropathy Grace C. Kimbaris, MD


8:00 am - 9:30 am

Session

NM Sports Medicine Case Based Presentations: A Mechanisms ApproachLone Star A

Using a case-based teaching approach, identify acute and chronic sports trauma injuries unique to each sport; utilize EDX and US in diagnosing these injuries; and explain current patient management.

8:00 am: Introduction and Overview of NM Sports Injuries Bryan X. DeSouza, MD

8:05 am: Mechanisms of Peripheral Nerve Injury in Sports Bryan X. DeSouza, MD

8:30 am: Sports Injuries of the Spine Francis P. Lagattuta, MD

8:55 am: Neuromuscular Sports Injuries of the Extremities Anthony G. Alessi, MD


8:00 am - 9:30 am

Session

Utilizing the Principles of Lifestyle Medicine for the Treatment of NM DiseaseLone Star F

Describe how a therapeutic lifestyle change can be an effective tool in the management of NM disorders; apply the principles of lifestyle medicine to foster resilience and prevent provider burnout.

8:00 am: Introduction John W. Norbury, MD

8:05 am: Meditation and What Are You Drinking?! Kristi Nord, MD

8:25 am: Case Review Gautam Malhotra, MD

8:50 am: Case Review John W. Norbury, MD


8:00 am - 9:30 am

Session

Molecular Therapy for SMA in Clinical PracticeLone Star C

Participants will gain increased knowledge regarding the molecular mechanism that control disease pathogenesis; outline emerging clinical trends in patient treatment and current research; describe clinical responsibilities of the care team involved in the management of SMA through an actual clinic model.

8:00 am: Introduction Diana Castro, MD

8:05 am: Molecular Basis of SMA Diana Castro, MD

8:30 am: Current Therapy for SMA in Clinical Practice Diana Castro, MD

8:55 am: Complex Drug Program: One Model Julie Parsons, MD


47 Saturday | October 19

8:00 am - 9:30 am

Session

Antibody Testing and NMDsLone Star B

Integrate the judicious application of antibody testing properly into NM medicine and accurately interpret results.

8:00 am: Introduction Yuebing Li, MD, PhD

8:05 am: Antibody Testing in Neuropathy and Myopathy Georgios Manousakis, MD

8:35 am: Antibody Testing in NMJ Disorder Michael K. Hehir, MD

9:00 am: Paraneoplastic Antibodies in NM Yuebing Li, MD, PhD

1.5 CME/CEU9:20 am: Discussion and Q&A

8:00 am - 9:30 am

Workshop

W07AS SFEMG and Measuring Jitter Using Concentric Needle

Demonstrate how jitter can be measured using CNE, and identify machine settings and limitations. Must be familiar with the basic concepts of SFEMG techniques.

Janice M. Massey, MD

1.5 CME Donald B. Sanders, MD

8:00 am - 9:30 am

Workshop

W11AS EMG and US Respiratory

Perform phrenic NCSs; utilize techniques for safe needle EMG of the diaphragm (including US assisted); localize and perform needle EMG of chest wall muscles, which are helpful in the diagnosis of respiratory failure; and utilize US for evaluating thickness and contractility of the diaphragm.

1.5 CME Andrea J. Boon, MD

8:00 am - 9:30 am

Workshop

W13AS Entrapment Lower Limb

Familiarize participants with techniques needed to evaluate and diagnose entrapments in lower limbs. Acquire skills to perform NCSs for peroneal, tibial, medial, and lateral plantar nerves; and identify the appropriate muscles for evaluating lower limb nerve entrapments and appropriate needle placement for EMG examination.

1.5 CME Michael T. Andary, MD, MS

8:00 am - 9:30 am

Workshop

W18AS NM US

Obtain images with transverse and longitudinal transducer positions; describe how to manipulate basic US instrumentation to include focal depth, Doppler flow, and transducer frequency; describe how muscle, nerve, and tendon appear with US; and discuss the principle of anisotropy.

1.5 CME/CEU Vanessa Baute, MD

8:00 am - 9:30 am

Workshop

W21AS NCS Pitfalls

Identify common instrumentation, physiologic, and operator errors; alter recording electrode montages and use the instrument’s filters to help optimize the recording of motor and sensory potentials; and minimize stimulus artifact interference with waveform recording.

1.5 CME/CEU Bassam A. Bassam, MD

8:00 am - 9:30 am

Workshop

W38AS Physical Exam of the Athlete: Cervical Spine and Upper Extremity

Examine an individual and determine if the pain is from the cervical spine, shoulder, elbow, wrist, hand or a muscle and identify the typical athletic injuries to these regions. Participants will determine which structure of the cervical spine is the pain generator, i.e., nerve root, facet joint or muscle; distinguish which shoulder structures are pain generators; determine a diagnostic and therapeutic plan; identify the key elements in a history and physical exam to make a diagnosis and discuss a proper diagnostic workup and treatment plan for the injured athlete; and discuss the differential diagnosis for cervical spine and upper extremity injuries in the athlete. Physical examination maneuvers useful in the diagnosis of radiculopathy and common nerve entrapment syndromes will be demonstrated.

1.5 CME/CEU Lawrence W. Frank, MD

48Saturday | October 19

8:00 am - 9:30 am

Workshop

W45AS Cervical Radiculopathy/Brachial Plexopathy

Discuss the anatomy of the cervical roots and the brachial plexus; describe the role of the sensory NCS in the initial localization of axon loss processes to preganglionic versus ganglionic/postganglionic; illustrate the role of the sensory NCS in localizing focal lesions to specific regions of the brachial plexus (root, trunk, division, cord, terminal nerve); discuss the role of motor NCS in further localizing the lesion and in defining its severity; describe the role of the needle EMG in confirming the NCS findings and in defining the temporal features of the disorder (slowly progressive, rapidly progressive, acute, subacute, chronic); and demonstrate this information using illustrative cases.

1.5 CME Ghazala R. Hayat, MD

8:00 am - 9:30 am

Workshop

W62AS NCS Workshop

Perform basic NCSs in the upper extremity and lower extremity as well as RNS; describe common pitfalls of NCSs; and identify the most common mononeuropathies in the upper and lower extremities.

Teresa Spiegelberg, CNCT, R.NCS.T, R.EEG.T, BS

1.5 CME/CEU Gary W. Gallagher, MD

8:00 am - 9:30 am

Workshop

W86AS Advanced US of Upper Limb Nerves

Explain recommended transducer frequencies and image optimization methods for imaging of upper extremity nerves; demonstrate scanning technique and measurement of the following nerves: musculocutaneous, MAC and LAC; describe and demonstrate the branching pattern of radial nerve from arm to wrist including PIN and superficial radial sensory; discuss sonographic findings of the most frequent abnormalities affecting these nerves; and list expected findings in structures other than nerve that may be significant. This workshop will focus on musculocutaneous, radial from arm to wrist including PIN and superficial radial sensory, MAC, LAC.

1.5 CME/CEU Monika Krzesniak-Swinarska, MD

9:30 am - 10:00 am

Social Event



10:00 am - 11:30 am

Session

Neurodiagnostic Jeopardy: Let Us Get on Your Nerves!Lone Star G-H

Identify the upper and lower limb anatomy beginning at the nerve root level and continuing down to the muscle with discussion of commonly seen abnormalities and their presentation on NCS and EMG.


Session is open to Technologists only.

10:00 am: Candy Dolan, CNCT, R.NCS.T, R.EEGT.

10:00 am: Jerry Morris, CNCT, MS, R.NCS.T.

1.5 CEU10:00 am: Teresa Spiegelberg, CNCT, R.NCS.T, R.EEG.T, BS

10:00 am - 12:00 pm

Session

Plenary 4: The Present & Future Role of Technology in the Lives of Patients With NM DiseasesLone Star D

Discuss the emerging technologies in NM US and how these changes will change the way physicians diagnose and manage NMs and MSDs.



10:25 am: Emerging Technologies in NM Ultrasound Lisa D. Hobson-Webb, MD


11:05 am: Annual Meeting 2020 Yuen T. So, MD, PhD


49

M

AR

CH

2019 R

AR

E N

EU

RO

LO

GIC

AL

DISE

ASE

SPE

CIA

L R

EP

OR

T

SU

PP

LE

ME

NT

TO

NE

UR

OL

OG

Y R

EV

IEW

S

SPECIAL REPORT

MARCH 2019

A SUPPLEMENT TO NEUROLOGY REVIEWS

Cell and Gene Therapy: Awaiting the Arrival of Transformative Medicine

Report: What’s Promising in the Drug Pipeline for Rare Neuromuscular Diseases?

Progress in Management of Lysosomal Storage Diseases

Fundamental Advances in Understanding Tourette Syndrome and How It Is Managed

A Member of the Network

SELECTED ARTICLES

25

30 73

62

MARCH 2019

SPECIAL REPORTA SUPPLEMENT TO NEUROLOGY REVIEWS

www.mdedge.com/neurology

Neurology Reviews is proud to announce the publication of its � fth annual Rare Neurological Disease Special Report. Articles include:• How Far Has Genetic Testing in Neurology Come? Where Is It Headed?

• Are State-by-State Differences in Newborn Screening an Impediment or Asset?

• The Promise and Setback of Gene Therapy with CRISPR/Cas9 Technology

• Cell and Gene Therapy: Awaiting the Arrival of Transformative Medicine

• Report: What’s Promising in the Drug Pipeline for Rare Neuromuscular Diseases?

• Anticipating Gene Therapies: A Rare Disease Database Is Racing to Close the Diagnostic Gap in Neuromuscular Diseases

• Gene-Based Therapy for Rare Pediatric Neuromuscular Disorders Puts Transition-of-Care Issues in the Spotlight

• Brief Report: Cannabidiol Approved for Treating Rare Epilepsies

• Rare Epileptic Encephalopathies: Update on Directions in Treatment

• Progress in Management of Lysosomal Storage Diseases

• What Are the Practical and Financial Aspects of Transitioning Patients From Pediatric to Adult Neurologic Care?

• Fundamental Advances in Understanding Tourette Syndrome and How It Is Managed

• Rare Diseases Aren’t as Rare as You Might Think: Look to the NIH’s Many Resources for Help

• NORD Offers Resources to Bene� t Health Care Providers, Patients, and Caregivers

• An Introduction to the New York Genome Center and a Look at Its Pioneering Work in ALS

• PKAN Overview and Disease Awareness

• Rare Diseases Pose a Pressing Challenge: Get the Diagnostic Work Done Swiftly

• An Overview of Moebius Syndrome: Diagnosis, Supportive Treatment, and Valuable Community Resources

• Update: The Search for Therapies for Succinic Semialdehyde Dehydrogenase De� ciency

FOR MORE INFORMATION, CONTACT:

Elizabeth Katz, Publisher, Neurology Reviews [email protected] 973-224-7951

NR NORD 2019 AANME fullpgAd.indd 1 5/10/19 11:23 AM

50

Lifetime Achievement Award – James W. Albers, MD, MSThe Lifetime Achievement Award is AANEM’s highest honor, recognizing an AANEM member who has been a major contributor in the fields of NM and EDX medicine over the course of their career. Dr. Albers likens his path to medicine as a “Walter Mitty adventure that had an unexpected but highly pleasant outcome.”

Reflecting on his life and career, Dr. Albers says he is most excited about the impact of technology (which is a focus of the 2019 AANEM Annual Meeting) on the future of neurology patient care, along with the exponential increase in the number of genetic and molecular mechanistic discoveries that he says have “changed how medicine is practiced in general.”

“My hope is that the importance of the clinical examination and the problem-solving skills developed by neuromuscular specialists remain an important part of the diagnostic and treatment process.”

Distinguished Physician Award – Robert A. Werner, MD, MSThis award recognizes a physician’s contributions as a clinician and educator as well as his overall support of AANEM activities. His outstanding work in the field of EDX medicine, especially as it pertains to teaching and publications, strong support of AANEM (he’s been an AANEM member since 1985) and long career in education contributed to his candidacy for this award.

His research spans more than 100 publications in peer reviewed journals and has secured grant funding from the likes of the NIH, CDC, NIOSH, UAW-GM Health and Safety and the US Postal Service. His accolades for research writing include nods from the Association of Academic Physiatrists, the American Academy of PM&R and the

American College Occupational and Environmental Medicine, along with a post on the Editorial Boards of Archives of PM&R, Muscle & Nerve, Journal of Occupational Rehabilitation, and Topics in Stroke Rehabilitation.

Advocacy Award – Benjamin S. Warfel, MDA longtime champion of his field and a strong supporter of AANEM, it is no surprise that Dr. Benjamin Warfel was named this year’s Advocacy Award recipient. Dr. Warfel has been an active member of AANEM since 1999. Over the last 2 decades he has acted as Pennsylvania’s State Liaison since the inception of the AANEM State Liaison Committee, and has represented AANEM at every “Hill Day” since they began, in which members go to Washington, DC, to lobby Congress and make them aware of needs in the fields of NM and EDX medicine.

“AANEM’s cause is more essential than ever as large corporations continue to be given leeway regarding patient quality,” Dr. Warfel said of his advocacy work. “These

corporations have been given the legal power to create captive patient populations, and to define to those patients what ‘quality’ is, rather than a national body of peer-reviewed experts like AANEM, which is not biased by profit maximization.”

2019 AANEM Achievement AwardsThe 2019 AANEM Achievement Awards will be presented during the Friday plenary session. Join us as we recognize the following individuals for their significant contributions to NM and EDX medicine. Read their full stories in your Summer 2019 edition of the AANEM EDGE.

51

Jun Kimura Outstanding Educator Award – Pushpa Narayanaswami, MBBS, DMDr. Narayanaswami radiates passion for neurology when speaking about the subject and advocating for its merits in the classroom. She has spent many years teaching neurology at various institutions, sports numerous evidence-based articles on her CV, and her work as a presenter on neurology-related topics over the last 2 decades is unparalleled.

Dr. Narayanaswami’s teachings have reached a worldwide audience. She has presented at various neurology-related conferences in India, Mexico and Austria, and has developed a muscular dystrophy mobile app in collaboration with the AAN.

“Neurology has always fascinated me; the preciseness of anatomical localization, the logical, almost mathematical diagnostic approach,” Dr. Narayanaswami says of her field.

Ernest Johnson Outstanding Educator Award – Jeffrey A. Strakowski, MDDr. Strakowski credits a visit from Dr. Johnson himself during Dr. Strakowski’s days as a medical student at Indiana University as helping pique his interest in PMR. “He seemed to dominate a multi-specialty sports medicine conference with a number of concepts that seemed foreign to many at the time, but later gained widespread acceptance,” Dr. Strakowski recalled. What followed has been nothing short of a stellar, decades-long career at The Ohio State University, with three PMR Department Teacher of the Year awards to his credit.

“I think that teaching is probably in my blood, as both of my parents are teachers,” Dr. Strakowski said. “They instilled in me and my brothers, the value of education at a very young age. I feel that I have been lucky enough to learn from very interested and

skilled teachers all through my academic career, and they have served as great role models for fostering my interest. I have noticed that the individuals that I looked up to and were inspired by the most, whether they were physicians, coaches or in other fields, always seemed to be the best teachers.”

Scientific Impact Award – Lisa D. Hobson-Webb, MDThe Scientific Impact Award recognizes mid-career AANEM members for serving as a first, second, or senior author on a published paper in a national or international peer-reviewed, indexed journal within the past several years. Dr. Hobson-Webb’s recent publication in Muscle & Nerve titled “Ultrasound in EMG-Guided Biopsies: A Prospective, Randomized Pilot Trial” contributed to her candidacy. The study revealed that ultrasound did not provide any added advantage when used to guide a biopsy within a muscle previously selected by EMG. Further studies will examine the role of muscle ultrasound in muscle selection.

“Many muscle biopsies are non-diagnostic, so I was looking for ways to improve the quality of testing by localizing sites of pathology using ultrasound,” she said of her

work. “I hope that others will use the information from this study to design larger and better studies on the topic of ultrasound-guided muscle biopsies.”

52

Scientific Impact Award – Sabrina Paganoni, MD, PhDThe Scientific Impact Award recognizes mid-career AANEM members for serving as a first, second, or senior author on a published paper in a national or international peer-reviewed, indexed journal within the past several years. Dr. Paganoni has been named as this year’s recipient given her second authorship on a December 2017 article in Muscle & Nerve titled “Phase IIa Trial of Fingolimod for Amyotrophic Lateral Sclerosis Demonstrates Acceptable Acute Safety and Tolerability.”

“I am incredibly honored to be the recipient of the AANEM Scientific Impact Award. I focused the first years of my career as a physician scientist on developing expertise in the development of innovative trial designs that can accelerate the path to effective

treatments for ALS,” Dr. Paganoni said. “My career goals today stay true to that mission. I am excited to be the Co-Principal Investigator of the HEALEY ALS Platform Trial, which is poised to transform the way we test investigational products for ALS.”

Distinguished Researcher Award – Craig M. McDonald, MDThere are very few physicians who have influenced the study of Duchenne muscular dystrophy (DMD) as much as Craig M. McDonald, MD. His seminal contributions as leader of the international CINRG (“Synergy”) Duchenne Natural History Study, which is credited with shedding light to the elucidation of the natural history of DMD, validation of the clinical endpoints now used in clinical trials of DMD throughout the world, the development of novel endpoints to assess more severely affected patients with DMD who are non-ambulatory, identification of genetic modifiers which affect DMD disease progression, and application of proteomics to identify novel candidate biomarkers for DMD clinical trials have all resulted in Dr. McDonald’s selection as this year’s AANEM Distinguished Researcher Award recipient.

“I never dreamed that we would be in a position over the next 30 years to offer dystrophin restoration treatments to boys and young men that would produce transformative outcomes through direct targeting of the DMD disease pathogenesis,” Dr. McDonald said of his life’s work. “It is incredibly rewarding as a physician scientist to generate natural history data and develop novel clinical endpoints used in clinical trials, and I have been excited to be able to offer my patients precision therapeutics that target the underlying causes of neuromuscular diseases and modifying the course of these complex multisystem diseases.”

Innovation Award – Ralph M. Buschbacher, MDLong before anyone thought about the nuances of NCSs, Dr. Ralph M. Buschbacher realized weaknesses existed regarding the foundation of the techniques and interpretations of clinical nerve conduction tests.

Due to his innovations in the field of electrodiagnostic medicine, Dr. Buschbacher has been nominated for this year’s AANEM Innovation Award.

“I knew enough from statistics that the values generally in use did not have a large enough sample size to be optimal,” Dr. Buschbacher said of his work. “There were limitations. I started this research just thinking about myself and my own patients, and

later realized that it had applicability to others as well. Age, gender, height, BMI, they weren’t being looked at as normative values. I thought the numbers had to be taken to the next level.”

53

Best Abstract Award Recipient – Tatsuya Oishi, MDNeuromuscular Morbidity: A Large Tertiary Care Center Experience (Abstract #1)

“From experience it was perceived that Hodgkin’s Lymphoma survivors (with an otherwise excellent outcome from the initial disease) treated with radiation as standard of care had a tendency to experience delayed neuromuscular complications, sometimes a few decades after

the initial therapy. This was characterized only to a very limited extent thus far, and we wished to fully capture the extent of this underappreciated series of long-term complications.”

Originally from Chicago, Dr. Oishi studied neuroscience at Emory University in Atlanta before returning home to attend medical school at the University of Illinois, Chicago. He recently completed his neurology residency at Mayo Clinic in Rochester, MN, and stayed for his current fellowship in clinical neurophysiology/EMG.

Best Abstract Award Runner-up – Facundo Heredia, MDHereditary Spastic Paraplegia: Clinical and Genetic Spectrum in a Selected Argentinean Group (Abstract #2)

Dr. Heredia’s abstract represented a country-wide effort to create a sense of urgency to conduct research on this disease. The objective was “to determine the clinical and molecular characteristics of a cohort of Argentinean patients with idiopathic spastic paraplegia.” The team

performed clinical, neurophysiological, laboratory, radiological, and genetic studies in 42 consecutive patients with HSP. Their ages ranged from 22 to 76, with two thirds of the patients being female. A 62-gene panel was performed using TruSight One and Agilent-focused Exome.

Dr. Heredia is a neurologist who just completed his postgraduate coursework at President Peron Hospital. He has a fellowship in NM diseases from the British Hospital of Buenos Aires. His wife is also a physician, a resident in pediatrics and neonatology.

2019 Abstract Award WinnersAANEM’s list of abstract award winners this year includes a stellar list of up and coming stars in the fields of neurology and PMR. Categories include the Best Abstract Awards, President’s Research Initiative Awards, Residency and Fellowship Member Recognition Awards, and the American Neuromuscular Foundation and IFCN Scholarships.

Abstract numbers are listed beside each winner’s name. We encourage you to congratulate these individuals and visit with them during the following times:• Thursday, October 17 from 1:00 pm-1:30 pm and 3:30 pm-4:00 pm (Posters numbers: 1-127)• Friday, October 18 from 1:00 pm-1:30 pm and 3:30 pm-4:00 pm (Poster numbers: 128-248)

There will also be an Abstract Presentation Reception on Thursday, October 17 from 5:45-6:45 pm located in the Lone Star Ballroom Foyer. The reception will feature the Best Abstract, Best Abstract Runner-up, and the President’s Research Initiative winners.

Best Abstract Award and Runner-upThe Best Abstract Award is given to the best research paper submitted to the AANEM Annual Meeting. All abstracts are considered for this award unless the authors indicate that they do not wish to be considered. For 2019, a Best Abstract Award winner and a runner-up were selected.

54

President’s Research Initiative AwardIn 2019, AANEM and American Neuromuscular Foundation President Anthony Chiodo chose the role of technology in the lives of patients with NM diseases as his topic for research for the AANEM Annual Meeting. Abstracts submitted on this topic are automatically considered for the President’s Research Initiative Award; however, only 10 abstracts or fewer are chosen to receive this honor.

2019 Award WinnersJun Li, MD, PhD (Abstract #3)James Bashford, MA, MRCP (Abstract #4)Rachel Pérez-Lalana, Msc (Abstract #5)

Bei Cao, MD (Abstract #6)Ronald Cotton, MD, PhD (Abstract #7)Armin Maghsoudlou, MD (Abstract #8)

Stephanie Wyrostek, DO (Abstract #21)Preston Douglas, MD (Abstract #25)Cheran Elangovan, MD (Abstract #30)Robin Warner, DO (Abstract #32 & 208)Thomas Torres Cuenca, MD (Abstract #34)Cynthia Wozow, DO (Abstract #54)Charbel El Kosseifi, MD (Abstract #61)Collin Grant, MD (Abstract #63)Carolina Vivar, MD (Abstract #67)Michael Lin, MD (Abstract #78)Nadim Jiwa, MBBS (Abstract #87 & 204)Shuja Sheikh, MD (Abstract #104 & 105)Mathieu Cuchanski, DO (Abstract #131)Tyler Klein, DO (Abstract #136)Noushin Jazebi, MD (Abstract #138 & 232)Kacper Pierwola, MD (Abstract #145 & 220)Lincoln Darla, MD (Abstract #147)Jordan Powell, MD (Abstract #151 & 178)Chichun Emily Sun, DO (Abstract #152)Drew Parkhurst, DO (Abstract #154)Sri Raghav Sista, MD (Abstract #155 & 211)Paige Harrison, DO (Abstract #156)

E. Ali Bateman, MD (Abstract #158)Rocio Vazquez Do Campo, MD (Abstract #164)Jacob Manske, MD (Abstract #170)James Noto, DO (Abstract #174)Kevin Moser, MD (Abstract #180)Anita Bell, DO (Abstract #181)Ian Bakk, MD (Abstract #184)Assia Meziane-Tani, MD (Abstract #187)Nicholas Spinuzza, MD (Abstract #188)Christopher Reece, MD (Abstract #190 & 212)Dominic Femminineo, DO (Abstract #197)Marcus Cimino, MD, MBA (Abstract #201)Austin Grant, MD (Abstract #202)Jordan VanderEnde, MD (Abstract #209)Natalia Gonzalez, MD (Abstract #210)Jessica Calandra, DO (Abstract #213)Nirav Sanghani, MD (Abstract #214)Pritikanta Paul, MBBS (Abstract #216 & 236)Sukanthi Kovvuru, MD (Abstract #218)Ryan Castoro, DO, MS (Abstract #223)Tiffany Pike-Lee, MD (Abstract #239)

Residency and Fellowship Member AwardThis award is meant to encourage young physician members to conduct research in NM and EDX medicine. The awards are given to AANEM members currently enrolled in a residency or fellowship program. Those who are the first and presenting author of an accepted abstract for the annual meeting receive a $200 cash reward.

2019 Award Winners

55

American Neuromuscular Foundation and IFCN Scholarship RecipientsThe American Neuromuscular Foundation and International Federation of Clinical Neurophysiology scholarships program provides an opportunity for physicians who practice in economically developing countries to apply for funds to support their education through attendance at the AANEM Annual Meeting.

American Neuromuscular Foundation Oleksandr Solonovych, MD, UkraineRoman Tretiakov, MD, UkraineChaoJun Zheng, MD, China

International Federation of Clinical Neurophysiology Salem Abdelhady, MD, EgyptN. Carolina González Alvarado, MD, ColombiaVitor Marques Calda, MD, BrazilBei Cao, MD, ChinaRezoug Chahrazed, MD, AlgeriaAyatAllah Farouk, MD, EgyptHaris Hakeem, MBBS, FCPS, PakistanFacundo A. Heredia, MD, ArgentinaNelsy Rocio Huertas-Romero, MD, ColombiaSruthi S. Nair, MD, DM, IndiaRachel Pérez-Lalana, MSc, CubaHanan H. Soliman, MD, EgyptThomas Torres Cuenca, MD, Colombia

Medical Student Research AwardThis award encourages medical students to conduct research in NM and EDX medicine. The award is given up to 10 medical students per year. Those who are bestowed the award receive $500 cash, recognition in the AANEM Annual Meeting Program and at the ANNEM Annual Meeting, and their abstract is published in Muscle & Nerve.

2019 Award WinnersTingting Hua, BS (Abstract #9)Catherine Rodriguez, BS (Abstract #10)Nikita Chhabra, MSIII, H.BSc. (Abstract #11)Joshua Kaltman, BS (Abstract #12)Andrew Sinensky, BS (Abstract #13)

Zahra Haider, BS (Abstract #14)Brian Blankenship, BS (Abstract #15)Tess Litchman, BA (Abstract #16)Esther Zusstone, BS (Abstract #17)Tara Torabi, MSc (Abstract #18)

56

Poster Hall

57

Silent AuctionStop by on Wednesday & Thursday!

View all the donations and make bids on items you like!

Instructions• To make a bid, write down the number found on your badge along with the dollar

amount of your bid.• Bids must be in by 4:00 pm on Thursday.• Check the Silent Auction lists to see if you won.• Winners can pay for their items between 10:00 am and 4:00 pm on Friday at the

Registration Booth.

All money raised from the Silent Auction goes to the American Neuromuscular Foundation to provide funds for scientific research on NM diseases.

Help us launch the newly branded American Neuromuscular Foundation!

All Annual Meeting attendees will be given a t-shirt to help celebrate this initiative. Be sure to pick up your shirt on level 3 on your way to the Plenary on Friday, October 18 between 9:30 and 10:00 am. Wear your shirt during the Plenary to show your support for strengthening the global effort to cure neuromuscular disease!

What Makes the ANF UniqueOver the last 3 years, the AANEM has transferred over $3 million to the Foundation and pays all of its expenses. The AANEM’s support makes the ANF unique so that when you donate, 100% of your money goes toward funding research and providing educational opportunities to future researchers.

Your Donation MattersIt takes approximately $60,000 per year to fund a research project. Every donation, big or small, helps continue the Foundation’s work. The Foundation is currently funding research in the following areas:• SMA - Spinal Muscular Atrophy• ALS - Lou Gehrig’s disease• Lambert Eaton Myasthenia• Kennedy’s disease• DNA sequencing to improve diagnosis of many

neuromuscular diseases

How YOU Can Help • Donate to the Foundation• Share our stories on your Facebook or other social

media pages• Encourage your patients to donate to the

Foundation or share their story with us• Wear your t-shirt on Friday!

Together we can make a difference in the lives of patients facing neuromuscular diseases.

58

ONPATTRO is a registered trademark of Alnylam Pharmaceuticals, Inc.© 2019 Alnylam Pharmaceuticals, Inc. All rights reserved. TTR02-USA-00055-032019

RNA=ribonucleic acid; RNAi=RNA interference.

Discover a novel approach to treating

a rare diseaseVisit Booth #501

to learn more about the first FDA-approved

RNAi therapeutic

6865_001_Onpattro 2020 Branded Congress Booth Evolution - AANEM Resized Ad_R1.indd 1 8/8/19 3:22 PM

59

ONPATTRO is a registered trademark of Alnylam Pharmaceuticals, Inc.© 2019 Alnylam Pharmaceuticals, Inc. All rights reserved. TTR02-USA-00055-032019

RNA=ribonucleic acid; RNAi=RNA interference.

Discover a novel approach to treating

a rare diseaseVisit Booth #501

to learn more about the first FDA-approved

RNAi therapeutic

6865_001_Onpattro 2020 Branded Congress Booth Evolution - AANEM Resized Ad_R1.indd 1 8/8/19 3:22 PM

60

AANEM’s Ultra EMG ProgramFebruary 19-22, 2020 – The Westin Fort Lauderdale in Florida

Enhance your knowledge of Ultrasound and EMG

Learn from leading experts, including course chair, Jeffrey A Strakowski, MD

Live demonstrations and practical skills sessions!

Registration opens in October 2019www.aanem.org/ultraemg

Objectives1. Review the fundamentals and basis of EDX medicine techniques. 2. Determine the best electrophysiologic tests for evaluating

peripheral neuropathies and other NM conditions.3. Review detailed peripheral nerve, MSK, and other relevant

anatomy of the upper and lower limbs, including appearance on US.

4. Observe, practice and improve skills with fundamental and advanced techniques in electrophysiology, MSK and NM US, and chemodenervation.

5. Review and practice EMG waveform identification.6. Learn image optimization with high frequency US.7. Learn the clinical value of high frequency US with basic and

complex MSK and NM conditions.8. Evaluate and improve report writing.9. Review and practice appropriate muscle selection for

chemodenervation.10. Review challenging cases incorporating both EDX and US.11. Review advancements in technology for assessing MSK and NM

disorders.

The AANEM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The AANEM designates this live activity for a maximum of 26 AMA PRA Category 1 Credits TM. Physicians should claim credit commensurate with the extent of their participation in the activity.

61

Play the AANEM Challenge and You Could Win a $250 Amazon Gift Card!How to Play:Visit these booths: • BioCureRX• Biogen• BriovaRx Infusion

Services• Cadwell• Catalyst

Pharmaceuticals• Cornithian Reference

Lab• CSL Behring• Diplomat Specialty

Pharmacy• Grifols USA, LLC• KabaFusion• Mayo Clinic

Laboratories• Momenta

Pharmaceuticals• NeuroPath DX• Nihon Kohden• Option Care• Sanofi Genzyme• Strongbridge

Take a photo/selfie at each of these booths (you must visit all 17 booths to qualify for the drawing).

Upload your 17 photos to the AANEM Challenge section of our meeting app.

Once you meet these requirements, you will be entered into a random drawing for a $250 Amazon gift card. One winner will be chosen Thursday evening and a second winner will be chosen Friday evening. Winners will be notified via email.

We’re looking forward to seeing your photos! Good luck!

62

ExhibitorsAkcea TherapeuticsBooth 101

Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and rare diseases. Akcea is advancing a mature pipeline of six novel drugs. Additional information about Akcea is available at www.akceatx.com. Wakefield, MA | www.akceatx.com

Alexion PharmaceuticalsBooth 301

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare and ultra-rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion has pioneered the complex field of complement biology and is committed to developing and delivering life-changing therapies to patients with devastating complement-mediated and metabolic disorders. Boston, MA | www.alexion.com

Allergan, IncBooth 314

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan’s website at www.Allergan.com. Irvine, CA | www.allergan.com

Alnylam PharmaceuticalsBooth 501

Alnylam is leading the translation of RNA interference into a new class of innovative medicines with the potential to transform the lives of people with rare genetic, cardio-metabolic, hepatic infectious, and CNS/ocular diseases. ONPATTRO® (patisiran) is Alnylam’s first U.S. FDA-approved RNAi therapeutic, with five investigational medicines in late-stage development. www.alnylam.com. Cambridge, MA | www.alnylam.com

Ambu Inc.Booth 421

Find us in the Exhibit Hall for more information. Glen Burnie, MD | www.ambuUSA.com

ArgenxBooth 606

Argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. argenx are focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need. Boston, MA | www.argenx.com

Authentic4DBooth 119

Authentic 4D’s FDA-approved, three-dimensional (3D) imaging platform provides unprecedented visualization and analysis of digital images from advanced medical equipment for use by insurers, attorneys, self-insureds and state funds to help lower indemnity expenses and litigation costs, enable faster case resolution, and improve reserve estimate accuracy on insurance claims. Bingham Farms, MI | www.authentic4d.com

AveXisBooth 104 & 106

AveXis is the world’s leading gene therapy company, reimagining the treatment of genetic diseases. We are focused on developing and delivering transformational gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. For more information, please visit AveXis.com. Bannockburn, IL | www.avexis.com

63

BioCure RXBooth 108

BioCureRx Specialty Pharmacy is a privately held company that specializes in high cost, high patient out-of-pocket, and clinically complex therapies that involve nursing care and/or training. BioCureRx is designed to provide solutions for the medical professionals, commercial payers, manufacturers, and most importantly the patient through the most advanced technologies. Houston, TX | www.biocurerx.com

BiogenBooth 619

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies.

Weston, MA | www.biogen.com

Biotek RemedysBooth 615

BioTek reMEDys is a leading specialty pharmacy providing medications and support services to patients, physicians, nurses, payers and pharma.

New Castle, DE | www.biotekrx.com

BreasBooth 607

Breas Medical manufactures high quality and comprehensive mechanical ventilators suited for all patient populations from infant through adults suited for hospital, long-term care and home environments. North Billerica, MA | www.breas.com

BriovaRx Infusion ServicesBooth 415

BriovaRx Infusion Services is a home infusion care provider serving patients across the U.S. with a national network of pharmacies. We specialize in Immune Globulin (IgG), Parenteral Nutrition (PN), Anti-infectives, Biologics, Inotropes and other specialty infusions. Our comprehensive services include specially trained on-staff nurses and pharmacists, around-the-clock clinical support,

reimbursement specialists and on-going patient education for safety and comfort.

Lenexa, KS | briovarxinfusion.com

Cadwell Laboratories, Inc.Booth 201

For 40 years Cadwell has combined customer insight, employee expertise, and cutting-edge innovation to deliver, and support our products with the goals of delighting our customers and improving the lives of patients. Sierra Summit seamlessly integrates an EDX study with Neuromuscular Ultrasound into a single procedure with a common user interface. Kennewick, WA | www.cadwell.com

Canon Medical Systems USA, Inc.Booth 613

Canon Medical Systems USA, Inc. delivers innovative medical solutions and services to improve the quality of life for all people. Specializing in diagnostic imaging, Canon Medical offers CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit us at us.medical.canon.

Tustin, CA | us.medical.canon

Catalyst Pharmaceuticals, Inc.Booth 414

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), MuSK antibody positive myasthenia gravis, congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) type 3. Catalyst has launched amifampridine, the only evidence-based, FDA-approved treatment for adult patients with Lambert-Eaton Myasthenic Syndrome (LEMS), it's the first product approved by the FDA for LEMS in more than 35 years. For more information on our work, please visit www.catalystpharma.com

Coral Gables, FL | www.catalystpharma.com

64

Corinthian Reference LaboratoryBooth 115

CRL is a commercial diagnostic laboratory specializing in neurological disease detection. We specialize in epidermal nerve fiber density (ENFD) testing. ENFD testing offers patients objective evidence of a neuropathy which can hopefully lead to a more accurate diagnosis. For additional information, please contact Greg Davenport at 480-330-3684.Benbrook, TX | www.corinthianreferencelab.com

CSL BehringBooth 401

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions such as CIDP, coagulation disorders, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. King of Prussia, PA | www.cslbehring.com

Diplomat Specialty PharmacyBooth 618

Diplomat Specialty Infusion Group is a national pharmacy and home infusion services provider specializing in the delivery of immune globulin therapy at home. We provide personalized support and attention to you and your patients, including post-infusion and trended reporting services for autoimmune neuropathies.

Learn more at www.diplomat.is/specialtyinfusion, or call 866.442.4679

Tampa, FL | www.diplomatpharmacy.com

EB NeuroBooth 614

Find us in the Exhibit Hall for more information.

Florence, Italy | www.ebneuro.com

Fujifilm SonoSiteBooth 323

Find us in the Exhibit Hall for more information. Bothell, WA | www.SonoSite.com

GBS/CIDP Foundation InternationalBooth 605

The GBS|CIDP Foundation International exists to improve the quality of life for individuals and families affected by GBS, CIDP, and related conditions. Our unwavering commitment to the patients we serve is built on four pillars: support, education, research and advocacy. We support patients by nurturing a global network of volunteers, healthcare professionals, researchers and industry partners to provide them with critical, timely, and accurate information. We educate doctors, clinicians, patients and caregivers to increase awareness and understanding. We fund research through grants, establishing fellowships and other appropriate avenues to identify the causes of and discover treatments. We advocate at the federal, state, and grassroots levels to educate policymakers and help them make informed decisions that benefit our patient community. Narberth, PA | www.gbs-cidp.org

GE HealthcareBooth 609

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world. Wauwatosa, WI | www.gehealthcare.com

65

Grifols USA, LLCBooth 215

For more than 75 years, Grifols has worked to improve the health and well-being of people around the world. We are a global healthcare company that produces essential plasma medicines for patients and provides hospitals, pharmacies, and healthcare professionals with the tools, information, and services they need to help them deliver expert medical care. Los Angeles, CA | www.grifols.com

InfuCare RxBooth 118

InfuCare Rx is a leading data driven specialty infusion services provider focused on immunoglobulin therapy (IVIG & SCIG) in the comfort of the patient's home or alternate care setting. Our dedicated team of pharmacists, nurses and other trained professionals strive to provide optimal patient outcomes through cost-effective, patient specific services. Fairfield, NJ | www.infucarerx.com

InvitaeBooth 603

Invitae’s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Our goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices. Visit www.invitae.com. San Francisco, CA | www.invitae.com

KabaFusion, LLCBooth 612

KabaFusion is a pharmacist-owned, patient-focused team of professionals with extensive experience in home infusion and specialty infusion therapy. Our pharmacists, nurses and reimbursement specialists work as a team to provide your patient with compassionate, efficient and reliable care. As a result, patients experience seamless coordination of care, reduced adverse events, reduced costs and optimization of their medical treatment. Edison, NJ | www.kabafusion.com

Kroger Specialty InfusionBooth 219

Kroger Specialty Infusion is a specialized home infusion provider for Subcutaneous Immune Globulin (SCIG) and IV Immune Globulin (Ig) for autoimmune and primary immune deficiency diseases. We provide an individualized care plan to ensure each patient achieves an optimal treatment outcome within a safe environment in their home, infusion suite, or physicians’ office. Torrance, CA | www.krogerspecialtyinfusion.com

Mayo Clinic LaboratoriesBooth 315

Our laboratories, led by clinical neurologists, offer a highly specialized test menu that provides answers for everything from the simplest to the most complex cases. Our neurologists are experts in their field and available seven days a week to help fellow physicians interpret each evaluation to provide clinically actionable answers, not just results. Rochester, MN | www.mayocliniclabs.com

Mitsubishi Tanabe Pharma AmericaBooth 209

Mitsubishi Tanabe Pharma America, Inc. (MTPA) is relentlessly focused on the goal of providing therapies for some of the most difficult-to-treat diseases, including amyotrophic lateral sclerosis (ALS). Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Jersey City, NJ | www.mt-pharma-america.com

Momenta Pharmaceuticals, Inc.Booth 100

Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Momenta’s product candidate, M281, is a potentially best-in-class anti-FcRn antibody and M254, is a hypersialylated human immunoglobulin (hsIgG) designed as a high potency alternative to intravenous immunoglobulin (IVIg). Cambridge, MA | www.momentapharma.com

66

Natus Neuro Booth 413

Natus Neuro is a global market leader that provides diagnostic, therapeutic and surgical solutions built on a strong heritage in neurodiagnostics, neurocritical care and neurosurgery. Natus Neuro delivers clinician-led products that improve outcomes and enhance care for neuro patients through leading-edge equipment, service, education and supplies. Middleton, WI | natus.com

NeuroPath Dx Booth 317

NeuroPath Diagnostics provides Epidermal Nerve Fiber Density Testing for the definitive diagnosis of small fiber neuropathy to help clinicians determine treatment options for their patients. All cases are read by David Saperstein, MD, Board Certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.

Dallas, TX | neuropathdx.com

Nihon Kohden America Booth 123

The Neuropack S3 is the latest and most innovative EDX system from Nihon Kohden. Our lightweight and portable solution features low-noise amplifiers and artifact-reduction software to provide cleaner, easier, and faster data. Neurodiagnostic tests include: EMG, NCS, Auditory EP, Somatosensory EP, Visual EP, Autonomics, and Event Related EPs. Irvine, CA | www.us.nihonkohden.com

Option Care Booth 214

Option Care offers industry-leading expertise, access, and support in IG home infusion therapy. Each year, we provide more than 80,000 IG home infusions across the country. We are contracted with more than 800 health plans and have a >96% success rate in overturning benefit denials.

Bannockburn, IL | www.optioncare.com

Pharnext Booth 507

Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase 3 trial with positive topline results in Charcot-Marie-Tooth disease type 1A and benefits from the orphan drug status. PXT864 generated encouraging Phase 2 results in Alzheimer’s disease. Pharnext has developed a new drug discovery paradigm based on Big Genomic Data and Artificial Intelligence called: PLEOTHERAPY™. Issy-Les-Moulineaux, France | www.pharnext.com

PTC Therapeutics Booth 116

PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

South Plainfield, NJ | www.ptcbio.com

Ra Pharmaceuticals Booth 520

Ra Pharmaceuticals utilizes a process called “mRNA display” and the Extreme Diversity™ platform to produce extremely large and diverse libraries of peptides from which to screen for potential product candidates. Ra Pharmaceuticals’ platform allows us to produce synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Doylestown, PA | rapharma.com

67

RDL Reference Laboratory Booth 611

RDL Reference Laboratory is a full service, autoimmune CLIA approved laboratory providing exclusive, quality assays for the practicing and academic Neurologist. We offer the most extensive Myositis Antibody Panel (MyoMarker 3+) and uniquely offer Anti-HMGCR Ab for statin-induced myonecrosis, and Anti-cN-1A Ab for sIBM. Also, RDL offers innumerable autoimmune disease assays. Los Angeles, CA | www.rdlinc.com

Rochester (Lifesync) Booth 218

Rochester (Lifesync), is a company committed to the development, marketing and sale of innovative products and accessories for Patient Monitoring and Neurodiagnostics; providing one of the most robust and diverse product lines in ECG, SpO2, NIPB, IBP, EMG, EEG, IOM, PSG, EP and Cath Labs.

Lutz, FL | www.advantagemed.com

Safersonic US, Inc. Booth 110

SAFERSONIC manufactures sterile ultrasound covers especially for Ultrasound Guided Procedures. We eliminate the need for gel under the cover saving time, money, and preventing damage from the cleaning process. No gel under the cover reduces artifacts and provides better visualization. Available in various lengths for different applications including 30 cm which is perfect for peripheral nerve blocks. SAFERSONIC fits all transducers. Reduce inventory costs. Upgrade your clinical practice, while upgrading patient care. SAVE TIME AND MONEY!

Highland Park, IL | www.safersonic.com

Sanofi Genzyme Booth 309

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new

therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.

Cambridge, MA | www.sanofigenzyme.com

Sarepta Therapeutics Booth 114

Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) MPS IIIA, Pompe and other CNS-related disorders, totaling over 20 therapies in various stages of development. Cambridge, MA | www.sareptatherapeutics.com

SpecialtyCare Booth 617

SpecialtyCare supports more than 13,500 surgeons in 1,100 hospitals with highly skilled people, equipment, and data that improve operating room efficiency, clinical outcomes and reduce overall costs. We perform over 400,000 procedures annually in cardiovascular perfusion, intraoperative neuromonitoring, minimally invasive surgical support, surgical first assistance, autologous transfusion services and sterile processing. Brentwood, TN | www.specialtycareus.com

Strongbridge Booth 519

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on therapies for rare diseases. Strongbridge has the only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of Primary Periodic Paralysis (PPP). PPP is a group of rare hereditary disorders that causes potentially severe episodes of muscle weakness and/or paralysis.

Trevose, PA | www.strongbridgebio.com

68

Takeda Pharmaceutical Company Limited Booth 109

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. www.takeda.com

Lexington, MA | www.takeda.com

The Electrode Store Booth 516

The Electrode Store is an ISO13485-certified manufacturer and distributor of electrodiagnostic supplies for EMG, EEG, and IONM. We offer monopolar and concentric needle electrodes, hypodermic needles for EMG-guided botulinum toxin injections, disposable and reusable surface electrodes, gels, pastes and more, with quick shipping, knowledgeable customer service, and low prices. Enumclaw, WA | www.electrodestore.com

Therapath Neuropathology Booth 112

Provides comprehensive diagnostic and consultative neuropathology services. New York, NY | www.therapath.com

US WorldMeds Booth 513

US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs. Louisville, KY | www.usworldmeds.com

WR Medical Electronics Company Booth 514

Physicians and researchers world-wide rely on WR Medical Electronics Co. for scientifically validated lab equipment and exceptional support during the life of their trials. Maplewood, MN | www.wrmed.com

69

Non-profit ExhibitorsHereditary Neuropathy FoundationHNF, a CMT advocacy and research organization leads efforts in the development of breakthrough treatments with its many stakeholder partnerships. With a commitment to patient-focused research, HNF has been instrumental in hosting the groundbreaking FDA El-PFDD meeting in 2018 and in the development of the first potential drug for CMT1A.

New York, NY | www.hnf-cure.org

National ALS Registry, CDC/ATSDRThe National ALS Registry collects data on people living with ALS in the United States. The Registry is a multi-faceted surveillance system that connects patients directly with clinical trials and epidemiological studies, collects specimens via the National ALS Biorepository, and funds ALS research on etiology and identification of risk factors.

Atlanta, GA | cdc.gov/als

Dysautonomia InternationalDysautonomia International is a 501(c)(3) non-profit that advocates for over 70 million individuals worldwide living with autonomic nervous system disorders through research, physician education, public awareness, and patient empowerment programs. Stop by our info table for clinician and patient education resources on POTS and other autonomic disorders.

East Moriches, NY | dysautonomiainternational.org

70

Exhibit Hall

71

72

73

74

The AANEM would like to recognize the following organizations for their financial support which was instrumental in making the 2019 AANEM Annual Meeting possible. Thank you for your commitment to

the AANEM and this educational initiative. We value your partnership!

Platinum Plus Support($125,000+)

Gold Support($65,000 - $94,999)

75

Industry Friends (Up to $24,999)

Silver Level Support($45,000 - $64,999)

76

Platinum Gift ($2,500 - $9,999)Yuen So, MD, PhD

Gold Gift($1,000 - $2,499)Jitendra Baruah, MDAnthony Chiodo, MD, MBAHolli Horak, MDJun Kimura, MDJames Leonard, MDJanice Massey, MDMichael Munin, MDDianna Quan, MDPerry Richardson, MDDavid SchildmeyerFaye Tan, MD

Silver Gift($250 - $999)Samuel Bierner, MDShawn Bird, MDAndrea Boon, MDRandall Braddom, MD, MSGregory Carter, MD, MSPeter Donofrio, MDWilliam Filer, MDPeter Grant, MDTaylor Harrison, MDLisa Hobson-Webb, MDRobert Irwin, MDYuebing Li, MD, PhDTeerin Liewluck, MDChristina Marciniak, MDMamatha Pasnoor, MDAtul Patel, MDAmanda Peltier, MD, MSCecile Phan, MDErik Pioro, MD, PhD, FRCP(C)Devon Rubin, MDMohammad Salajegheh, MDZachary Simmons, MDDavid Simpson, DO, MS

John Singleton, MDEric Sorenson, MDMary Spires, MD, PT, MAChannarayapatna Sridhara, MDVincent Tranchitella, MD Bonnie Weigert, MD

Bronze Gift($50 - $249)Shirlyn Adkins, JDRaymond Alcuri, MDPrasunamba Amaraneni, MDMichael Andary, MD, MSErica Austin, DOBassam Bassam, MDJames Beegan, MDMark Bernhard, DOBarbara Bess, MDKaren Bontia, MDDavid Chad, MD, FRCP(C)Jasvinder Chawla, MBBS, MD, MBABruce Cleeremans, MDBrian Couri, MDThomas Cowan, MDCormac DalyPhilip Davenport, MSc, MDEduardo De Sousa, MDMichael DeMarco, DOEric Denys, MDBryan DeSouza, MDGurpreet Dhaliwal, MDTimothy Dillingham, MD, MSMark Domroese, MD, PhDAndrew Dubin, MD, MSRonald Duerksen, MDLester Duplechan, MDBakri Elsheikh, MBBS, FRCPJose Fernandez, MD, PhDKaren Gade-Pulido, MDRonald Gaines, MD, MAAndrew Haig, MDGhazala Hayat, MDTerry Heiman-Patterson, MDSomkiat Hemtasilpa, MD

Lewis Herzbrun, MDSusan Hubbell, MD, MSDaniel Ignacio, MDCharles Jablecki, MDDeanna Janora, MDShelly JonesEun Jong Kim, MDMohamed Kazamel, MDKathleen Kennelly, MD, PhDFrancis Lagattuta, MD Tanya Lehky, MDMegan Leitch, MDJeffrey Lemberg, MDKerry Levin, MDJau-Shin Lou, MD, PhD, MBAE. Matthew Hoffman, MDMatthew Miller, MDMatthew Murnane, MDBipinchandra Patel, MBBChDouglas Pavlak, MDDavid Polston, MDMichael Polydefkis, MDHernan Posas, MDKevin Puzio, MDAmani Ramahi, MDMarcel Reischer, MDLawrence Robinson, MDManijeh Ryan, MDMarcy Schlinger, DOElena Shanina, MD, PhDLiane Sher, MDSteven Shook, MDKenneth Silver, MDChristine Smith, MDMasahiro Sonoo, MD, PhDKathryn Stolp, MD, MSSeneca Storm, MDChristina Taddeo, MDJames Teener, MDBruce ToddBryan Tsao, MDDustin Tyler, PhDEroboghene Ubogu, MDW. Alaric VanDam, MDLoretta VanEvery, MDMary Vargo, MD

Vettaikorumakankav Vedanarayanan, MD, FRCP(C)John Vlattas, MDJerry Weissman, MDScot WickClaire Wolfe, MDAmy Zarrin, MD, PhDLan Zhou, MD, PhD

Gift (up to $49)Hoda Abdel-Hamid, MDTaimour Alam, MbChb, MRCPMalaz Almsaddi, MD Bernardo Araújo, MDJulian BauerStephen BeckBrian Boyle, MDJennifer Carl, MDNaoichi Chino, MDLiviu Craciun, MD, PhDGiovanni D’AprileRoby DavisDenise DeVitoEric Gierke, MDMercedes Gil Marques, MDAndre Granger, MD, MBAJenny Guerre, MDKamran Hakimian, MDReiner Henson See, MDGoran Jezic, MDRosina Medel, MDDonna Moore, MDJoel Moradkhani, MDTrevor Nogueira, MDMohan Pillai, MDAlicia Quiroga, MDJames Ragland, MDMarat Reyzelman, MDTodd Silverman, MDBlake SkahanRobert Smith, MD, PhDPierre-Richard Theard, MDGlenn Thomas, MDDavid Wiechers, MD, MS, MBALinda WilliamsHaixiang Xu

The AANEM and ANF are thankful for every donation and hope that this list continues to grow each year, inspiring others to join the effort to cure neuromuscular disease. The American Neuromuscular Foundation is a 501©(3) nonprofit corporation. Your donation is tax-deductible

to the extent allowed by law.(Contributions listed were received between August 18, 2018 and August 20, 2019).

STRENGTHENING the global effort to CURE neuromuscular disease

Donate to the American Neuromuscular Foundation atwww.neuromuscularfoundation.org/Donate

Platinum Pledge ($2,500 - $9,999)John Kincaid, MD William Pease, MD

77

The AANEM would like to thank the many contributors of the AANEM Advocacy Fund. Your donations help give a voice to those who are fighting neuromuscular diseases, whether it be in the halls

of Congress or at home as a patient. (Contributions listed were received between August 18, 2018 and August 20, 2019).

Michael T. Andary, MD, MSMichele L. Arnold, MDJitendra K. Baruah, MDBassam A. Bassam, MDJulian BauerBarbara R. Bess, MDAnna P. Bettendorf, MDSamuel M. Bierner, MDKaren M. Bontia, MDBrian F. Boyle, MDCyril O. Burke, MDJennifer W. Carl, MDDavid A. Chad, MD, FRCP(C)Jasvinder PS Chawla, MBBS, MD, MBAWynde Cheek, DONaoichi Chino, MDBrian A. Couri, MDThomas B. Cowan, MDLiviu Craciun, MD, PhDGiovanni Antonio D’Aprile, MDPhilip A. Davenport, MSc, MDRoby DavisEduardo Adonias De Sousa, MDMichael DeMarco, DOBryan X. DeSouza, MDGurpreet Dhaliwal, MDMark E. Domroese, MD, PhDEric P. Gierke, MDRaghav Govindarajan, MDAndre Granger, MD, MBAPeter A. Grant, MDJenny Guerre, MDHope S. Hacker, MDKamran Hakimian, MDGhazala Riaz Hayat, MDTerry Heiman-Patterson, MDLewis J. Herzbrun, MDLisa D. Hobson-Webb, MDE. Matthew Hoffman, MDDeanna M. Janora, MDShawn Jorgensen, MDFrancis P. Lagattuta, MD

Sam-Gyu Lee, MD, PhDJames A. Leonard, MDChristina M. Marciniak, MDJanice M. Massey, MDRosina Medel, MDJoel Anthony Moradkhani, MDMichael C. Munin, MDAurelio Alfonso Muzaurieta, CNCT, R.NCS.T, RVTAtul T. Patel, MDBipinchandra R. Patel, MBBChDouglas M. Pavlak, MDWilliam S Pease, MDAmanda C. Peltier, MD, MSMohan Aiyaswami Pillai, MDHernan N. Posas, MDKevin J. Puzio, MDAlicia E. Quiroga, MDAmani Ramahi, MDMarat L. Reyzelman, MDKatalin Scherer, MDMarcy C. Schlinger, DOReiner Henson Barrios See, MDElena Shanina, MD, PhDLiane Sher, MDTodd B. Silverman, MDDavid A. Simpson, DO, MSDavid John Sinclair, MDChristine N. Smith, MDBirute G. Stewart, MDAANEM in memory of Jill SukJames W. Teener, MDBryan E. Tsao, MDDustin Tyler, PhDEroboghene E. Ubogu, MDW. Alaric VanDam, MDJohn S. Vlattas, MDRobert S. Wallach, DOBenjamin S. Warfel, MDPablo Brea Winckler, MDAmy R. Zarrin, MD, PhDLan Zhou, MD, PhD

78

Neuromuscular Update Course CommitteeRuple S. Laughlin, MDMichele L. Arnold, MDBassam A. Bassam, MDSara Dehbashi, MDKevin F. Fitzpatrick, MDLaura Y. Huang, MDKatarzyna Ibanez, MDShawn Jorgensen, MDDivpreet Kaur, MDJustin Y. Kwan, MDZachary N. London, MDDustin Nowacek, MDAndrew J. Skalsky, MDVettaikorumakankav Vedanarayanan, MD, FRCP(C)Sumit Verma, MDAmanda L. Witt, MD

Program CommitteeShawn Jorgensen, MDA. Gordon Smith, MDShirlyn A. Adkins, JDBei Cao, MDEarl J. Craig, MDBryan X. DeSouza, MDJames R. Dorman, MDAndrew Galbreath, DOCristian Ionita, MDPati L. Ramsey, CNCTPerry B. Shieh, MD, PhDJeffrey A. Strommen, MDLisa M. Williams, MDGil I. Wolfe, MD

Special Interest Group/Symposia CommitteeEricka P. Simpson MDRyan Castoro, DO, MSWilliam Filer, MDAnne G. Hartigan, MDE. Matthew Hoffman, MDJ. Chad Hoyle, MDJeffrey G. Jenkins, MDVita G. Kesner, MD, PhDJustin Y. Kwan, MDGabrielle Nguyen, MD

Gregory Robbins, MD

Technologist Education CommitteeShawn J. Bird, MDJerry Morris, CNCTSamuel M. Bierner, MDArun K. Chandok, MDCandy Dolan, CNCTMark A. Ferrante, MDLynn Sigston, CNCTT. Darrell Thomas, MDLoretta M. VanEvery, MD

Ultrasound CommitteeMonika Krzesniak-Swinarska, MDLester S. Duplechan, MDLisa D. Hobson-Webb, MDPeter Inkpen, MDH. Alexander Krob, MDSabeena Malik, MBBSSarada Sakamuri, MDElena Shanina, MDJeffrey A. Strakowski, MDShumaila Sultan, MD

Workshop CommitteeIleana Howard, MDKatharine E. Alter, MDAli Arvantaj, CNCTSaid R. Beydoun, MDKathleen H. Burgess, MDPhilip S. Hsu, MDMohamed Kazamel, MDJin Li, PhDDaniel L. Menkes, MDRenee A. Schwarz, CNCT

Acknowledgments & AppreciationThe AANEM Annual Meeting involves countless hours of planning, coordination, and execution, and takes a variety of people behind the scenes to make it happen. AANEM would like to thank the following committee and staff members for their contributions to the 2019 meeting.

AANEM StaffShirlyn A. Adkins, JD

Executive Director

Mary Kay CostelloAssoc. Executive/HR Support

Scott GerdesFinance Director

Shelly JonesCorporate Relations & Foundation

Director

Whitney LuttekeCommunications & Graphic

Designer

Ruth MichelProduct/Membership Specialist

Christy OgdenSr. Education Project Coordinator

Tracy ParksSr. Meeting Coordinator

Jay SchwinefusMarketing & Membership Director

Jacob SokolIT Director

Robbie Spencer

Sr. Communications & Membership Coordinator

Millie Suk, JD, MPPHealth Policy Director

Gwenda TiegenSr. Meeting Coordinator

Anna Vredenburg Professional Standards Sr.

Coordinator

Carrie Winter, RHIA Health Policy Manager

79

PresidentAnthony E. Chiodo, MD, MBA

Secretary-TreasurerHolli A. Horak, MD

President-ElectYuen T. So, MD, PhD

Past PresidentEric J. Sorenson, MD

DirectorsLisa D. Hobson-Webb, MDRobert W. Irwin, MDMichael C. Munin, MD Dianna Quan, MDDevon I. Rubin, MDBonnie J. Weigert, MD

Resident/Fellow Leadership LiaisonsJulia Reilly, MDRocio Vazquez do Campo, MD

2018 - 2019Board of Directors The AANEM’s volunteer Board of Directors is responsible for the association’s strategic planning, policy creation, financial oversight, and executive director supervision.

AANEM ANNUAL BUSINESS MEETING

The AANEM Business Meeting will be held on Wednesday, during Plenary 1.

There will be much to discuss at this year’s meeting, including a vote by Fellow,

Active, and Research members on new Board nominations. You’ll also hear a

report on AANEM’s finances and recent activities of importance to membership.

HistorianJohn C. Kincaid, MD

Executive DirectorShirlyn A. Adkins, JD

Seating is limited and first come, first serve for all meeting attendees.Lunch will be provided by AANEM for session attendees. This activity is not part of the official scientific program of the AANEM.

Visit Booth #414 to learn more about LEMS © 2019 Catalyst Pharmaceuticals, Inc.

All Rights Reserved.Printed in USA. 19LEM0215 August 2019

See what people are talking about Lambert-Eaton myasthenic syndrome (LEMS) in adults

WHY LEMS IN ADULTS WARRANTS A CLOSER LOOK:CLINICAL INSIGHTS AND COMMON MISDIAGNOSES

Presented by Perry B. Shieh, MD, PhDFriday, October 18 12:00 PM – 1:15 PMGrand Ballroom 2-4

80

AANEM: American Association of Neuromuscular & Electrodiagnostic MedicineABEM: American Board of Electrodiagnostic MedicineABPN: American Board of Psychiatry & NeurologyABPMR: American Board of Physical Medicine and RehabilitationACCME: Accreditation Council for Continuing Medical EducationALS: Amyotrophic Lateral SclerosisAMA: American Medical AssociationANF: American Neuromuscular FoundationBONT: Botulinum NeurotoxinCEU: Continuing Education UnitCIDP: Chronic Inflammatory Demyelinating PolyradiculoneuropathyCIPN: Chemotherapy Induced Peripheral NeuropathyCK: Creatine KinaseCMAP: Compound Muscle Action PotentialCME: Continuing Medical EducationCNCT: Certified Nerve Conduction Technologist

CNE: Concentric Needle ElectrodesCT: Computed TomographyCTS: Carpal Tunnel SyndromeCVT: Clinical Video TelehealthDMD: Duchenne Muscular DystrophyEDX: ElectrodiagnosticEMG: ElectromyographyFACS: Fellow American College of SurgeonsFDA: Food & Drug AdministrationFVC: Forced Vital CapacityGBS: Guillain-Barré SyndromeHCP: Health care providerICPI: Immune checkpoint inhibitorIFCN: International Federation of Clinical NeurophysiologyIOM: Intraoperative MonitoringIVIG: Intravenous ImmunoglobulinLAC: Lateral Antebrachial Cutaneous NerveLEMS: Lambert-Eaton myasthenic syndromeLFCN: Lateral Femoral Cutaneous NerveLOPD: Late-Onset Pompe DiseaseMAC: Medial Antebrachial Cutaneous NerveMG: Myasthenia GravisMGFA: Myasthenia Gravis Foundation of America

MMN: Multifocal motor neuropathyMRI: Magnetic Resonance ImagingMSD: Musculoskeletal DisorderMSK: MusculoskeletalMUAP: Motor Unit Action PotentialMUP: Motor Unit PotentialNAP: Nerve action potentialNCS: Nerve Conduction StudyNM: NeuromuscularNMDS: Neuromuscular DisordersNMJ: Neuromuscular JunctionMMN: Multifocal Motor NeuropathyNYSDOH: New York State Department of HealthPIN: Posterior Interosseous NervePNS: Peripheral Nervous SystemPNS: Peripheral Nerve SocietyPPC: Professional Practice CommitteePRA: Physician’s recognition awardPT: Physical TherapistRPNI: Regenerative Peripheral Nerve InterfacesRNS: Repetitive Nerve StimulationSA: Self-AssessmentSFEMG: Single-fiber ElectromyographySMA: Spinal Muscular AtrophyUS: Ultrasound

Abbreviations

81

Speaker IndexAlessi, Anthony: 41, 46Allen, Jeffrey: 30Allen, Tristin: 40Alter, Katharine: 19Amato, Anthony: 26Andary, Michael: 47Avila, J. David: 21Bassam, Bassam: 16, 30, 47Baute, Vanessa: 47Beauchamp, Jon: 17Beydoun, Said: 25, 42Biliciler, Suur: 31, 40Bird, Shawn: 30, 46Boon, Andrea: 27, 47Boulis, Nicholas: 33 Brault, Jeffrey: 27Bromberg, Mark: 31, 41, 45Caldas, Vitor Marques: 17Cartwright, Michael: 16, 32, 38Castro, Diana: 46Cederna, Paul: 13, 39Chawla, Jasvinder: 16, 26, 30, 33Chémali, Kamal: 23Chestek, Cynthia: 34Chiodo, Anthony: 1, 24, 28, 39, 48, 54Comer, Adam: 40Cornblath, David: 30Corrigan, Madeline: 13, 28Cutter, Gary: 17Davis, Eric: 18, 21Del Toro, David: 36DeSouza, Bryan: 46Dillingham, Timothy: 36, 39Dimachkie, Mazen: 20, 30Dimitrova, Alexandra: 27Dolan, Candy: 48Donofrio, Peter: 35, 41Duplechan, Lester: 19, 22Edmundson, Christyn: 46Elliott, Michael: 22Ensrud, Erik: 42Feldman, Eva: 41Ferrante, Mark: 21, 36, 42, 43Fichtner, Miriam: 17Filer, William: 44Forrest, Elizabeth: 37Gallagher, Gary: 43, 48Gilchrist, James: 16Goodman, Brent: 23

Grant, Peter: 26Guidon, Amanda: 31, 35, 43Guptill, Jeffrey: 17Gwathmey, Kelly: 37, 41Harrison, Taylor: 19, 42Hartigan, Anne: 38Hayat, Ghazala: 23, 48Hearn, Sandra: 21Hehir, Michael: 17, 43, 47Hobson-Webb, Lisa: 13, 16, 37, 48, 51Horak, Holli: 21Howard, Ileana: 22Howard, James: 17Inkpen, Peter: 27Izenberg, Aaron: 37Jacobson, Ryan: 41, 43Jaradeh, Safwan: 41Jayaraman, Arun: 13, 39, 44Joyce, Nanette: 46Juel, Vern: 15Kang, Peter: 38, 44Katirji, Bashar: 15, 18, 42Katzberg, Hans: 41Kazamel, Mohamed: 18, 21Kesner, Vita: 33Khoury, Julie: 26Kimbaris, Grace: 46Kimura, Jun: 17, 19, 29, 36Kincaid, John: 21Klein, Christopher: 32Kolb, Noah: 31Krzesniak-Swinarska, Monika: 20, 48Kung, Theodore: 34Kushlaf, Hani: 22Kusner, Linda: 17Kwan, Justin: 31, 40Ladha, Shafeeq: 15Lagattuta, Francis: 46Laidlaw, Ann: 38Laughlin, Ruple: 15Law, Nancy: 17Lee, Ikjae: 17Lehky, Tanya: 44Leonard, James: 34Levin, Kerry: 27Lewis, Richard: 31, 45Li, Yuebing: 47Litchy, William: 16, 34Little, Ann: 38

82

RESPIRATORY INVOLVEMENTIN NEUROMUSCULAR DISORDERS: Pompe Disease as a Prototype

Speakers:

Wednesday,October 1612:00 pm - 1:15 pm

JW Marriott AustinRoom: JW Marriott Ballroom 2-4

This activity is not part of the official scientificprogram of the AANEM Annual Meeting.

Sanofi Genzyme (SGZ) may not provide meals to certain persons at this SGZ sponsored Satellite Symposium. By accepting a meal at this program, you represent that none of these descriptions apply to you: (1) Minnesota or New Jersey prescriber; (2) healthcare provider licensed in Vermont (physician, nurse, pharmacist, etc.); (3) anyone prohibited from accepting things of value such as the food or drink at this event by other state or federal laws, or by his or her employer’s policies. Sanofi Genzyme thanks you for your understanding. In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at this program is limited to healthcare professionals. Accordingly, attendance by guests or spouses is not permitted.

© 2019 Genzyme Corporation. All rights reserved.Sanofi and Genzyme are registered in the U.S. Patent and Trademark Office SGUSMA.PD.07.0435 Expires: 10/17/19

C

M

Y

CM

MY

CY

CMY

K

AAMEM AD copy.pdf 1 8/7/2019 11:53:38 AM

Kenneth Berger, MD NYU, Division of Pulmonary, Critical Care, and Sleep Medicine

Mazen M. Dimachkie, MD Dept. of Neurology, Kansas University Medical Center

Speaker Index continued

Lou, Jau-Shin: 25, 44Madigan, Nicolas: 32Malhotra, Gautam: 46Manousakis, Georgios: 47Martinez-Thompson, Jennifer: 40Massey, Janice: 25, 43, 47Massie, Rami: 38Mauermann, Michelle: 18Mauricio, Elizabeth: 27McFarland, Dennis: 13, 28McMillan, Hugh: 44Mehta, Paul: 40Milone, Margherita: 30, 32Morris, Jerry: 40, 48Munin, Michael: 19, 22Naddaf, Elie: 38Narayanaswami, Pushpa: 17, 51Norbury, John: 16, 19, 46Nord, Kristi: 46Nowacek, Dustin: 43Nowak, Richard: 17Oskarsson, Bjorn: 40Park, Tracy: 19Parsons, Julie: 46Patel, Atul: 20, 21, 26

Patel, Kamakshi: 21Peltier, Amanda: 19, 30, 33, 41Phan, Cecile: 31Polston, David: 16Preston, David: 16, 42Quan, Dianna: 21Rivner, Michael: 17Robbins, Gregory: 34Robinson, Lawrence: 27, 34, 37Rosenfield, David: 18Roy, Pragma: 17Rubin, Devon: 27, 33, 38, 42Ruhoy, Ilene: 27Sakamuri, Sarada: 16, 22, 38Salajegheh, Mohammad: 37Sanders, Donald: 43, 47Shaibani, Aziz: 27Shanina, Elena: 20, 22Shieh, Perry: 30, 39Shook, Steven: 23Shroff, Sheetal: 18Simmons, Zachary: 13, 24, 26, 36, 41Simpson, Ericka: 18Singer, Adam: 33

Singleton, John: 41Smith, A. Gordon: 24, 41Smith, Benn: 26, 31So, Yuen: 48Sorenson, Eric: 40Spiegelberg, Teresa: 48Staff, Nathan: 40Staten, Stephanie: 18Strakowski, Jeffrey: 17, 22, 29, 32, 37, 40, 51Stubblefield, Michael: 21Stunnenberg, Bas: 35, 44Tan, Faye: 37Tavee, Jinny: 27Trevino, Christopher: 31Tsao, Bryan: 42VanEvery, Loretta: 40Verma, Aparajitha: 18, 21Vernino, Steven: 23, 30, 33Vullaganti, Mithila: 40Walsh, Edward: 17Weigert, Bonnie: 47Zaidman, Craig: 16Zhou, Lan: 25

A community dedicated to improving the livesof patients with neuromuscular diseases.

Join AANEM Today!The premier association in neuromuscular & electrodiagnostic medicine.

• More than 5,000 members strong• An exceptional annual scientific meeting • Free and discounted educational products • Collaboration and leadership opportunities• The prestigious Muscle & Nerve journal• Advocates working on your behalf• Funding for research • So much more!

Visit www.aanem.org/Value-of-Membership

Website: aanem.org Facebook: @AANEMorg Twitter: @AANEMorg

Eleven years ago, as a neuromuscular fellow, Aiesha Ahmed, MD, was encouraged by her mentors to attend the AANEM Annual Meeting. It was an educational experience Dr. Ahmed will never forget and she’s been a member of AANEM ever since!

“

“

One of the unique aspects of AANEM is the opportunity for collaboration between neuromuscular neurology and physical medicine and rehabilitation.

~ Aiesha Ahmed, MD

84

Your AANEM session break destination

•Get coffee and see a live Hizentra self-administration• Thursday and Friday 9:30 am • 3:00 pm

Important Safety InformationHizentra is indicated for:

• Treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years and older.

• Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability and impairment.

- Limitation of Use: Maintenance therapy in CIDP has been systematically studied for 6 months and for a further 12 months in a follow-up study. Continued maintenance beyond these periods should be individualized based on patient response and need for continued therapy.

For subcutaneous infusion only.

WARNING: Thrombosis may occur with immune globulin products, including Hizentra. Risk factors

may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors.

For patients at risk of thrombosis, administer Hizentra at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.

Hizentra is contraindicated in patients with a history of anaphylactic or severe systemic reaction to human immune globulin (Ig) or components of Hizentra (eg, polysorbate 80), as well as in patients with immunoglobulin A deficiency

with antibodies against IgA and a history of hypersensitivity. Because Hizentra contains L-proline as stabilizer, use in patients with hyperprolinemia is contraindicated.

IgA-deficient patients with anti-IgA antibodies are at greater risk of severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with Ig products, including Hizentra.

Monitor patients for aseptic meningitis syndrome (AMS), which may occur following treatment with Ig products, including Hizentra. In patients at risk of acute renal failure, monitor renal function, including blood urea nitrogen, serum creatinine and urine output.

In addition, monitor patients for clinical signs of hemolysis or pulmonary adverse reactions (eg, transfusion-related acute lung injury [TRALI]).

Hizentra is derived from human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent and its variant (vCJD), cannot be completely eliminated.

The most common adverse reactions (observed in ≥5% of study subjects) were local infusion-site reactions, as well as headache, diarrhea, fatigue, back pain, nausea, extremity pain, cough, upper respiratory tract infection, rash, pruritus, vomiting, upper abdominal pain, migraine, arthralgia, pain, fall, and nasopharyngitis.

The passive transfer of antibodies can interfere with response to live virus vaccines and lead to misinterpretation of serologic test results.

Please see full prescribing information for Hizentra, including boxed warning.

See a LIVE DEMO of Hizentra

Be part of our interactive case-based learning• Watch a live Hizentra self-administration

• Get hands on with the equipment

• Hear a Hizentra patient share real-life experiences

• Review results from PATH—the largest study in CIDP

The next step in CIDP maintenance therapy— only at Booth #401

Live Demo

Booth #401

FPO

85

Your AANEM session break destination

•Get coffee and see a live Hizentra self-administration• Thursday and Friday 9:30 am • 3:00 pm

Important Safety InformationHizentra is indicated for:

• Treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years and older.

• Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability and impairment.

- Limitation of Use: Maintenance therapy in CIDP has been systematically studied for 6 months and for a further 12 months in a follow-up study. Continued maintenance beyond these periods should be individualized based on patient response and need for continued therapy.


WARNING: Thrombosis may occur with immune globulin products, including Hizentra. Risk factors

may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors.

For patients at risk of thrombosis, administer Hizentra at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.

Hizentra is contraindicated in patients with a history of anaphylactic or severe systemic reaction to human immune globulin (Ig) or components of Hizentra (eg, polysorbate 80), as well as in patients with immunoglobulin A deficiency

with antibodies against IgA and a history of hypersensitivity. Because Hizentra contains L-proline as stabilizer, use in patients with hyperprolinemia is contraindicated.

IgA-deficient patients with anti-IgA antibodies are at greater risk of severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with Ig products, including Hizentra.

Monitor patients for aseptic meningitis syndrome (AMS), which may occur following treatment with Ig products, including Hizentra. In patients at risk of acute renal failure, monitor renal function, including blood urea nitrogen, serum creatinine and urine output.

In addition, monitor patients for clinical signs of hemolysis or pulmonary adverse reactions (eg, transfusion-related acute lung injury [TRALI]).

Hizentra is derived from human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent and its variant (vCJD), cannot be completely eliminated.

The most common adverse reactions (observed in ≥5% of study subjects) were local infusion-site reactions, as well as headache, diarrhea, fatigue, back pain, nausea, extremity pain, cough, upper respiratory tract infection, rash, pruritus, vomiting, upper abdominal pain, migraine, arthralgia, pain, fall, and nasopharyngitis.

The passive transfer of antibodies can interfere with response to live virus vaccines and lead to misinterpretation of serologic test results.

Please see full prescribing information for Hizentra, including boxed warning.

See a LIVE DEMO of Hizentra

Be part of our interactive case-based learning• Watch a live Hizentra self-administration

• Get hands on with the equipment

• Hear a Hizentra patient share real-life experiences

• Review results from PATH—the largest study in CIDP

The next step in CIDP maintenance therapy— only at Booth #401

Live Demo

Booth #401

FPO

86

HIZENTRA®, Immune Globulin Subcutaneous (Human), 20% LiquidInitial U.S. Approval: 2010

BRIEF SUMMARY OF PRESCRIBING INFORMATION

These highlights do not include all the information needed to use HIZENTRA safely and effectively. See full prescribing information for HIZENTRA.

WARNING: THROMBOSIS

See full prescribing information for complete boxed warning.

• Thrombosis may occur with immune globulin products, including HIZENTRA. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors.

• For patients at risk of thrombosis, administer HIZENTRA at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.

-----------------------------------INDICATIONS AND USAGE-----------------------------------

HIZENTRA is indicated for:*Treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years and older.* Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability and impairment.-Limitation of Use: Maintenance therapy in CIDP has been systematically studied for 6 months and for a further 12 months in a follow-up study. Continued maintenance beyond these periods should be individualized based on patient response and need for continued therapy.


-------------------------------DOSAGE FORMS AND STRENGTHS----------------------------0.2 g per mL (20%) protein solution for subcutaneous injection

-------------------------------------CONTRAINDICATIONS--------------------------------------• Anaphylactic or severe systemic reaction to human immune globulin or components of

HIZENTRA, such as polysorbate 80• Hyperprolinemia (type I or II) (HIZENTRA contains the stabilizer L-proline)• IgA-deficient patients with antibodies against IgA and a history of hypersensitivity

-------------------------------WARNINGS AND PRECAUTIONS--------------------------------• IgA-deficient patients with anti-IgA antibodies are at greater risk of severe

hypersensitivity and anaphylactic reactions.• Thrombosis may occur following treatment with immune globulin products, including

HIZENTRA.• Aseptic meningitis syndrome has been reported with IGIV or IGSC, including HIZENTRA

treatment.• Monitor renal function, including blood urea nitrogen, serum creatinine, and urine

output in patients at risk of acute renal failure.• Monitor for clinical signs and symptoms of hemolysis.• Monitor for pulmonary adverse reactions (transfusion-related acute lung injury [TRALI]) • HIZENTRA is made from human plasma and may contain infectious agents, e.g., viruses,

the variant Creutzfeldt-Jakob disease (vCJD) agent and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

-------------------------------------ADVERSE REACTIONS---------------------------------------The most common adverse reactions observed in ≥5% of study subjects were local infusion site reactions, headache, diarrhea, fatigue, back pain, nausea, pain in extremity, cough, upper respiratory tract infection, rash, pruritus, vomiting, abdominal pain (upper), migraine, arthralgia, pain, fall and nasopharyngitis.

To report SUSPECTED ADVERSE REACTIONS, contact CSL Behring Pharmacovigilance at 1-866-915-6958 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

----------------------------------------DRUG INTERACTIONS------------------------------------The passive transfer of antibodies may interfere with the response to live virus vaccines, and lead to misinterpretation of the results of serological testing.

Based on March 2018 revision

Hizentra is manufactured by CSL Behring AG and distributed by CSL Behring LLC. Hizentra® is a registered trademark of CSL Behring AG.

Biotherapies for Life® is a registered trademark of CSL Behring LLC.©2019 CSL Behring LLC 1020 First Avenue, PO Box 61501, King of Prussia, PA 19406-0901 USA

www.CSLBehring.com www.Hizentra.com HIZ-0980 SEP19

See a LIVE DEMO of HizentraThe next step in CIDP maintenance therapy—

only at Booth #401

Your AANEM session break destination •Get coffee and see a live Hizentra self-administration• Thursday and Friday 9:30 am • 3:00 pm

Live Demo

Booth #401

87

Meeting ObjectivesThe following objectives for the 2019 meeting were developed:The 2019 annual meeting will focus on improving patient care, medical knowledge, interpersonal communication, professionalism, and systems based practices in the following areas: updates in NM and MSK disorders; genetics and emerging gene therapies; autoimmune disorders; neuropathies; antibody testing; integrative medicine, US, EDX, respiratory, and biopsy skills.

After attending this activity, attendees will:• Enhance their ability to obtain a

comprehensive patient history and examination; improve their ability to develop a differential diagnosis and direct appropriate diagnostic work-ups; assess rehabilitation potential for patients with NM and MSK disease; treat patients with pain; recognize how emerging technologies in US, robotics, and exoskeleton technology can improve the lives of patients. (Patient care)

• Develop technical skills necessary to perform neurologic, EDX, and rehabilitative procedures; identify and describe important EDX, biopsy, genetic, and US findings; develop awareness, treatment, therapies, and side effects; and discuss the latest literature on NM disorders. (Medical knowledge, Practice-based learning)

• Improve ability to communicate with and educate patients, families, and members of the healthcare team; develop awareness of ethical and biomedical legal issues related to patient care; enhance awareness of patient confidentiality issues as they relate to patient care; demonstrate professionalism in clinical, research, and academic practice; and demonstrate skills in end-of-life care. (Interpersonal communication skills, Professionalism)

• Develop strategies for working in a multidisciplinary session, awareness of cost of emerging treatments; identify and access supportive healthcare services and mechanisms that improve patient care and patient quality of life. (Systems-based practice)

Accreditation StatementThe AANEM is accredited by theAccreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation StatementThe AANEM designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Self-Assessment CreditTen courses at the 2019 annual meeting will be designated to offer Part II MOC Self-Assessment credit for physicians. AANEM will report completion of this self- assessment activity to ABPN and ABPMR.

Disclaimer StatementAANEM will disclose to learners the relevant financial relationships for those in control of CME content prior to the educational activity or disclose that there were no relevant financial relationships. Information will be provided through print and verbal disclosures.

AANEM Annual Meeting Refund PolicyThe association dedicates a significant amount of time and expense to deliver a great annual meeting each year. While we hope everyone who registers for the annual meeting will be able to attend, we understand that circumstances may sometimes prevent this from happening. AANEM has established the following policy for those who request a refund.

Refund requests received from 13 days, through the start of on-site registration, will be subject to a $150 cancellation fee and any remaining amount will be credited toward future AANEM purchases (credit expires 2 years after the first day of the annual meeting). Registration fees will not be refunded after the start of on-site registration*.

*Individual workshops, events, or sessions that were purchased in addition to the standard registration fee may be cancelled during the meeting, as long as the attendee has not cancelled their standard meeting registration. A refund of 50% of the purchase price will be provided. The ticket must be returned to the registration desk to receive a refund.

AANEM CME ProgrammingIt is the policy of the AANEM to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. This program is for scientific and educational purposes only and will not, directly or indirectly, promote the interests of any commercial interest. All CME sessions that are offered as part of the official AANEM Annual Meeting program are determined solely by the AANEM Annual Meeting planning committees and approved by the AANEM Board. Planning committees identify professional practice gaps, choose topics and identify session chairs for each session, and determine the educational format. Material presented at the sessions cannot contain any advertising, corporate logo, trade name, or product-group message. All scientific research referred to, reported or used in support of justification of a patient care recommendation will conform to generally accepted standards of experimental design, data collection and analysis. Speakers are requested to provide a balanced view of therapeutic options, using generic names in presentations to contribute to impartiality. If content includes trade names, speakers are instructed to incorporate the trade names from several companies.

Specific disclosure information for all speakers, planning committee members and course chairs participating in the 2019 Annual Meeting is provided in the Disclosure Index at the registration desk or online at www.aanem.org/disclosures.

Industry ForumsIndustry Forums are commercially supported educational activities held in conjunction with the AANEM Annual Meeting. These satellite symposia sessions are not part of the AANEM’s official annual meeting program and are planned by an outside company or party. These sessions are clearly labeled as Industry Forums to allow the participant to be fully aware of any bias in the presentations. Seating at sessions is limited, and food is provided by the AANEM to Industry Forum attendees on a first come, first-served basis.

Date post:	12-Apr-2020
Category:	Documents
Upload:	others
View:	2 times
Download:	0 times

WELCOME TO THE AANEM ANNUAL MEETING...Silent Auction | Lone Star Ballroom Foyer Visit the Silent...

Documents